Postoperatieve pijn

Initiatief: NVA Aantal modules: 68

Clonidine als additivum aan lokaal anestheticum

Uitgangsvraag

Wat is de plaats van alfa-2-agonist clonidine als additivum aan lokaal anestheticum aan het locoregionaal of neuraxiaal blok bij kinderen die een chirurgische ingreep ondergaan?

 

Voor clonidine intraveneus/oraal, zie module Clonidine.

Aanbeveling

Overweeg clonidine toe te voegen als adjuvans aan een lokaal anestheticum voor een perifere of neuraxiale zenuwblokkade, wanneer een verlengend analgetisch effect gewenst is. 

Overwegingen

Voor- en nadelen van de interventie en de kwaliteit van het bewijs

Er is literatuuronderzoek verricht naar de gunstige en ongunstige effecten van de toevoeging van de alfa-2-agonist clonidine aan het locoregionaal blok bij kinderen die een chirurgische ingreep ondergaan. Er zijn 28 RCT’s geïncludeerd in de literatuursamenvatting. De operaties die de kinderen ondergingen waren divers. In de meeste studies werd clonidine als additivum aan een lokaal anestheticum bij een caudaal blok onderzocht, in enkele studies betrof het een perifere zenuwblokkade, zoals dorsaal penis blok of buikwandblok.

 

De studies waren doorgaans klein en hadden methodologische beperkingen. Hierdoor was er risico op vertekening van resultaten (risk of bias) en werd de optimale populatiegrootte (OIS) niet behaald door kleine aantallen. Daarom is de bewijskracht voor alle uitkomstmaten in meer of mindere mate afgewaardeerd. Bovendien werden in de geïncludeerde studies verschillende meet- en rapportage methoden gebruikt (bijvoorbeeld verschillende pijn meetinstrumenten zoals Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS) en de

Children and Infants Postoperative Pain Scale (CHIPPS); en verschillen in rapportages zoals mediaan of gemiddelden) of waren de resultaten gelimiteerd beschreven in de studies, waardoor het bij de meeste uitkomstmaten niet mogelijk was om de resultaten te poolen. Derhalve zijn de resultaten vaak per studie beschreven.

 

Postoperatieve pijn op 0, 6 en 24 uur was gedefinieerd als cruciale uitkomstmaat. Voor postoperatieve pijn was de bewijskracht laag. De totale bewijskracht komt daarmee uit op laag. Alleen op 6 uur na de operatie werd een mogelijk pijn verlagend effect gevonden in het voordeel van de toevoeging van clonidine; op 0 uur en 24 uur na was een geen verschil in effect.

 

Angst, postoperatief gebruik van opioïden, en adverse events (apneu, ademhalingsdepressie, hypotensie, sedatie, en delirium) waren gedefinieerd als belangrijke uitkomstmaten.

Voor adverse events apneu en delier werd geen bewijs gevonden. Voor de uitkomstmaten hypotensie en sedatie is de bewijskracht literatuur laag en toont het bewijs dat er mogelijk geen verschil is in effect tussen de onderzochte groepen.

 

Samenvattend kan de literatuur onvoldoende richting geven aan de besluitvorming. De aanbeveling is daarom gebaseerd op aanvullende argumenten waaronder expert opinie, waar mogelijk aangevuld met (indirecte) literatuur.

 

Clonidine heeft mogelijk een positief effect op postoperatieve pijn na 6 uur wanneer dit wordt toegevoegd aan lokaal anesthetica. Er is zijn beperkte resultaten op latere tijdspunten, dus over de duur van het mogelijke positieve effect is geen uitspraak te doen. Er zijn geen nadelige effecten van het toedienen van clonidine als adjuvans naar voren gekomen in deze literatuurstudie.  Het toevoegen van clonidine kan dan ook veilig gebruikt worden als adjuvans en is te overwegen.

 

Waarden en voorkeuren van patiënten (en evt. hun verzorgers)

Voor de ouders en de patiënt is goede pijnbestrijding met zo min mogelijke bijwerkingen belangrijk. Van de patiënt of ouders van de patiënt kan men niet verwachten dat deze zoveel kennis van medicatie heeft om de keuze voor toevoeging van clonidine aan het locoregionaal blok kan maken te bespreken. Deze keuze dient te worden gemaakt door de behandelend zorgverlener, op basis van zijn/haar kennis en ervaring. De patiënt en ouders mogen verwachten van de behandelend arts dat deze de kennis heeft van de medicatie om een keuze van medicament te maken.

 

Kosten (middelenbeslag)

Clonidine is een goedkoop middel en zal bij implementatie niet tot substantieel hogere kosten leiden. Ten opzichte van andere alfa-2-agonisten, zoals dexmedetomidine, is het een goedkoper medicament.

 

Aanvaardbaarheid, haalbaarheid en implementatie

De werkgroep is van mening dat implementatie er geen bezwaren zijn op het gebied van aanvaardbaarheid of haalbaarheid. Clonidine behoort tot de standaard anesthesiemiddelen en is daardoor breed beschikbaar. Bij de keuze voor dit middel dienen uiteraard de contra-indicaties van clonidine in acht genomen te worden.

 

Rationale van de aanbeveling: weging van argumenten voor en tegen de interventies

Er zijn aanwijzingen dat toevoegen van clonidine mogelijk een positief additief effect heeft op de analgetisch effect van lokaal anesthetica bij perifere en neuraxiale zenuwblokkades. Het toevoegen van clonidine aan een lokaal anestheticum lijkt niet te leiden tot een toename van adverse events. De medicatie brengt minimale kosten met zich mee en minimale bezwaren ten aanzien van implementatie. Dit alles in acht nemend is het toevoegen van clonidine aan lokaal anesthetica te overwegen.

Het Kinderformularium heeft een doseringsadvies beschreven voor clonidine als adjuvans bij andere analgetica (Clonidine, Kinderformularium).

Onderbouwing

Regelmatig worden er zowel neuraxiale blokken (caudaal of epiduraal) geplaatst bij kinderen als perifere zenuwblokkades. Bij beide groepen kan het gaan om een singleshot techniek of met een katheter voor continue pijnstilling. Er wordt dan gebruik gemaakt van een lokaal anestheticum waarbij soms een additivum gebruikt wordt. Clonidine, een alfa-2-agonist kan toegevoegd worden als additivum. Het doel van een additivum is de duur van het blok verlengen en het gebruik van opioïden te verlagen en mogelijk angst te verminderen.

Postoperative pain

Low GRADE

Clonidine as adjuvant to a local anesthetic may result in little to no difference in postoperative pain at PACU arrival/ 0 hours when compared with a local anesthetic alone in children undergoing a surgical procedure.

 

Source: Anouar 2016; Bhati 2022; El-Hennway 2009; Joshi 2004; Koul 2009; Mostafa 2021; Potti 2017; Tripi 2005; Visoiu 2021

Low GRADE

Clonidine as adjuvant to a local anesthetic may result in reduced postoperative pain at 6 hours when compared with a local anesthetic alone in children undergoing a surgical procedure.

 

Source: Anouar 2016; Bhati 2022; Jindal 2011; Narasimhamurthy 2016; Parameswari 2010; Potti 2017; Visoiu 2021

Low GRADE

Clonidine as adjuvant to a local anesthetic may result in little to no difference in postoperative pain at 24 hours when compared with a local anesthetic alone in children undergoing a surgical procedure.

 

Source: Anouar 2016; Bhati 2022; El-Hennway 2009; Joshi 2004; Mostafa 2021; Narasimhamurthy 2016; Potti 2017; Visoiu 2021

 

Anxiety

Very low GRADE

The evidence is very uncertain about the effect of clonidine as adjuvant to a local anesthetic on anxiety when compared with local anesthetic alone in children undergoing a surgical procedure.

 

Source: Visoiu, 2021

 

Postoperative opioid consumption

Very low GRADE

The evidence is very uncertain about the effect of clonidine as adjuvant to a local anesthetic on postoperative opioid consumption in PACU when compared with local anesthetic alone in children undergoing a surgical procedure.

 

Source: Anouar 2016; Joshi 2004; Tripi 2005

Very low GRADE

The evidence is very uncertain about the effect of clonidine as adjuvant to a local anesthetic on postoperative opioid consumption in 24 hours when compared with local anesthetic alone in children undergoing a surgical procedure.

 

Source: Joshi 2004; Tripi 2005

Very low GRADE

The evidence is very uncertain about the effect of clonidine as adjuvant to a local anesthetic on total postoperative opioid consumption when compared with local anesthetic alone in children undergoing a surgical procedure.

 

Source: Akin 2010; De Negri 2001; Ivani 2000; Kalachi 2007; Tripi 2005

 

Adverse events

No GRADE

No evidence was found regarding the effect of clonidine as adjuvant to a local anesthetic compared with local anesthetic alone on adverse events apnea and postoperative emergence delirium in children undergoing abdominal surgery.

 

Source: -

Low GRADE

Clonidine as adjuvant to a local anesthetic may result in little to no difference in adverse events respiratory depression and hypotension when compared with a local anesthetic alone in children undergoing a surgical procedure.

 

Sources respiratory depression: Akbas 2005; Akin 2010; Bajwa 2010; Bhati 2022; El-Hennway 2009; Koul 2009; Narasimhamurthy 2016; Parameswari 2010; Potti 2017; Sanwatsarka 2017; Shaikh 2015; Singh 2012; Tripi 2005

 

Sources hypotension: Akbas 2005; Akin 2010;  El-Hennway 2009; Parameswari 2010; Potti 2017; Sanwatsarka 2017; Shaikh 2015; Singh 2012; Tripi 2005

Low GRADE

Clonidine as adjuvant to a local anesthetic may result in little to no difference in sedation when compared with a local anesthetic alone in children undergoing a surgical procedure.

 

Source: Bawja 2010; Ivani 2000; Jindal 2011; Koul 2009; Potti 2017; Mostafa 2021; Narasimhamurthy 2016; Sanwatsarka 2017; Tripi 2005; Visoiu 2021

 

Description of studies

A description with study characteristics of each RCT is presented in Table 1. As shown in the table, studies were conducted in patients undergoing various surgeries. Number of patients per arm varied from 15 to 50. The mean age of children in the studies varies from 3 years to almost 14 years. The percentage of males was often not specified, but for the studies that did report the sex of the patients, the male percentage was high.

 

Table 1: Descriptives of included studies.

Author, year
country

 

Population (I/C), mean age; sex (M/F)

Surgical procedure

Intervention

Control

Akbas, 2005

 

Turkey

N: 25/ 25

Age (years) ± SD: 6.08 ± 2.87/

5.64 ± 3.13

M:F: not reported

Inguinal hernia repair and circumcision

ropivacaine 0.2% 0.75 ml/kg)

plus clonidine 1 µg/kg) (group RC)*

caudal block

received ropivacaine 0.2%, 0.75 ml/kg) (group R)*

 

*Drugs were diluted in 0.9% saline (0.75 ml/kg )

Akin, 2010

 

Turkey

N (I1/I2/C): 20/ 20/ 20

Age (years) ± SD: 4.1 ± 2/ 4.1 ± 2/

4.1 ± 2

M:F: not reported

Inguinal hernia repair or orchidopexy surgery

I1: Levobupivacaine 0.25% 0.75 ml/kg) and 2 µg/kg) clonidine caudally and 5 ml normal saline i.v. (Group L-Ccau)

 

I2: Levobupivacaine 0.25%, 0.75 ml/kg) and 2 µg/kg) clonidine in 5 ml normal saline i.v. (Group L-Civ)

Levobupivacaine 0.25% 0.75 ml/kg) and 5 ml normal saline i.v (group L)

Anouar, 2016

 

Tunisia

N: 20/ 20

Age (months) ± SD: 30 ±3.12/

25.2 ± 5

M:F: 20:0/20:0

Day-case male circumcision

ml/Kg of bupivacaine 0.5% with 1 µg/kg of clonidine in each side

dorsal penile nerve block

0.1 ml/kg of bupivacaine 0.5% with placebo in each side

Bajwa, 2010

 

India

N: 22/ 22

Age (years) ± SD: 3.4 ± 1.42 /

3.1 ± 1.68

M:F: not reported

Elective lower abdominal surgery (hernia surgery)

 

0.25% ropivacaine, 0.5 ml/kg, with an addition of 2 µg/kg clonidine via the caudal route*

0.25% ropivacaine, 0.5 ml/kg*

 

*with a total volume being constant at 0.5 ml/kg in both the study groups

Bhati 2022

 

India

N: 20/ 20

Age (years) ± SD: 3.85 ± 1.39/

3.40 ± 1.31

M:F: 20:0/20:0

Infraumbilical elective surgery

caudal injection of 0.25% levobupivacaine at a dose of 1 mL/kg body weight with clonidine 0.5 µg/kg

caudal injection of 0.25% levobupivacaine at a dose of 1 mL/kg body weight

De Mey, 2000

 

Belgium

N: 30/ 30

Age (months) ± SD: 39.1 ± 29.4/ 38.3 ± 32.2

M:F: 30:0/30:0

Hypospadias repair

0.5 mL kg−1 bupivacaine 0.25% caudally + 1 μg kg−1 clonidine (group II)

0.5 mL kg−1 bupivacaine 0.25% caudally (group I)

De Negri, 2001

 

Italy

N (I1/I2/I3/C): 15/ 15/ 15/ 15

Age (months) ± SD:

31 ±10/ 28±14/ 32 ±9/ 28 ± 12

M:F: 15:0/ 15:0/ 15:0/ 15:0

Hypospadias repair

 

I1: ropivacaine 0.08% 0.16 mg/kg/h plus clonidine 0.04 mg/kg/h

(Group RC1)

 

I2: ropivacaine

0.08% 0.16 mg/kg/h

plus clonidine 0.08

mg/kg/h (Group RC2)

 

I3: ropivacaine 0.08%

0.16 mg/kg/h plus clonidine 0.12 mg/kg/h

(Group RC3)

Epidural

plain ropivacaine 0.1% 0.2 mg/kg/h

(Group R)

El-Hennway, 2009

 

Egypt

N: 30/ 30

Age (months) (range): 45 (6–69)/ 43 (7–66)

M:F: not reported

Lower abdominal surgeries

bupivacaine 0.25% (1 ml/ kg) with clonidine 2 mg/kg in normal saline 1 ml

caudal block

bupivacaine 0.25% (1 ml/kg) with normal saline 1 ml

Ivani, 2000

 

Italy

N: 20/ 20

Median age (years) (range):

3 (1–7)/ 3 (1–7)

M:F: 16:4/ 18:2

Elective sub-umbilical surgery

caudal block with 1 ml/kg of ropivacaine 0.1% with

the addition of clonidine 2 mg/kg

 

caudal

block with 1 ml/kg of ropivacaine 0.2%

 

Jindal, 2011

 

India

N: 25/ 25

Age (months) ± SD: 8.48 ± 7.11/

7.92 ± 6.48

M:F: 17:8/19:6

Elective cleft lip repair

clonidine from a 150 μg/ml ampoule was diluted and 1 μg/kg was drawn with a tuberculin syringe and added to 0.5 ml of 0.5% bupivacaine;

the resulting mixture was reconstituted with saline to a volume of 1 ml to maintain a bupivacaine concentration of 0.25%

solution of 1 ml 0.25% bupivacaine solution was prepared by adding 0.5 ml saline to 0.5 ml of 0.5% bupivacaine

Joshi, 2004

 

USA

N: 18/ 17

Age (months) ± SD: 28 ± 22 /

44 ± 31

M:F: 3:15/ 2:15

Unilateral hernia,

hydrocelectomy, or orchidopexy

2 µg/kg) of clonidine

(100 µg/ml) in addition to the bupivacaine.

Caudal block

equal volume of

preservative-free normal saline

Koul, 2009

 

India

N: 20/ 20

Age (years) ± SD: 3.45 ± 2.06/ 3.28 ± 1.65

M:F: not reported

Inguinalherniotomy

Caudal epidural injection of 0.75ml/kg of 0.25% bupivacaine with 2 μg/kg of clonidine

 

Caudal epidural injection of 0.75 ml/kg of 0.25% bupivacaine

Laha, 2012

 

India

N: 15/ 15

Age (years) ± SD: 4.8 (±2.6)/

4.7 (±2.6)

M:F: 11:4/11:4

Lower abdominal, perineal, and

lower limb surgeries

 

caudal injection of mixture of ropivacaine 0.2% (1 ml/kg) with clonidine 2 μg/kg

caudal injection of plain ropivacaine 0.2% (1 ml/kg)

Mostafa, 2021

 

Egypt

N: 30/ 30

Age (years) ± SD: 5.68 ± 1.7/

5.37 ± 1.6

M:F: not reported

Laparoscopic orchiopexy

levobupivacaine plus clonidine

transversus abdominis plane block

levobupivacaine plus normal saline

 

Narasimhamurthy, 2016

 

India

N: 30/ 30

Age (years) ± SD: 4.8 + 1.7/

4.7 + 1.7

M:F: 25:5/ 26:4

Infraumbilical surgeries (circumcision, herniotomy and orchidopexy)

mixture of 0.2% Ropivacaine and preservative free Clonidine 1 μg/kg.

caudal block

mixture of 0.2% Ropivacaine and normal saline

Parameswari, 2010

 

India

N: 50/ 50

Age (months):

19/ 21

M:F: 47:3/ 47:3

 

Subumbilical

surgeries under general anesthesia (circumcision; orchidopexy; herniotomy)

Bupivacaine with 1 μg/kg clonidine caudal block

Plain bupivacaine

Potti, 2017        

 

India

N (I1/I2/C): 25/ 25/ 25

Age (years) ± SD: 4.7 ± 2/ 4.6 ± 1/ 4.32 ± 2

M:F: not reported

Elective infraumbilicial surgeries 

I1: Group B (n = 25) received levobupivacaine 0.25% 1 mL/kg with 1 µg/kg clonidine caudally and 5 mL of normal saline i.v

 

I2: Group C (n = 25) received levobupivacaine 0.25% 1 mL/kg caudally and 1 µg/kg clonidine in 5 mL normal saline i.v

Group A (n = 25) received levobupivacaine 0.25% 1 mL/kg caudally and 5 mL of normal saline i.v

 

Priolkar, 2016

 

India

N: 30/ 30

Age (years) ± SD: 4.43+1.52/

4.63+1.73

M:F: not reported

 

Infraumbilical operations

Group: BC: Mixture of 1 ml/kg of 0.125% bupivacaine with preservative free clonidine 1 μg/kg.

Caudal block

Group: B: 1 ml/kg of 0.125% bupivacaine solution

Rawat, 2019

 

India

N: 32/ 32

Age (years) ± SD: 4.14 ± 1.05/

4.16 ± 1.87

M:F: 15:7/14:8

Elective perineal surgeries

Group III – 0.25% levobupivacaine (1 mL/kg) with clonidine 1 µg/kg

Caudal block

Group I - 0.25% levobupivacaine (1 mL/kg)

Sanwatsarkar, 2017

 

India

 

N: 25/ 25

Age (years) ± SD: 6.28 ± 1.21/

6.64 ± 1.29

M:F: 23:2/22:3

Umbilical surgeries under general anesthesia

Group BC received 1 ml/kg 0.25% bupivacaine + 1 μg/kg clonidine in normal saline

Caudal block

Group B received 1 ml/

kg 0.25% bupivacaine in normal saline

Shaikh, 2015

 

India

N: 30/ 30

Age (months) ± SD: 58.30 ± 27.92/

74.40 ± 37.34

M:F: 27:3/ 28:2

 

Elective sub-umbilical, perineal and lower limb surgeries

Group B received caudal 0.25% bupivacaine 1 ml/Kg with clonidine 1 μg/Kg as an adjuvant made to 0.5 ml with normal saline

Group A received caudal  0.25% bupivacaine plain with 0.5 ml Normal saline

Singh, 2012

 

Nepal

N: 20/ 20

Age (years) ± SD: 5.45±2.5 /

6.10 ± 2.19

M:F: not reported

Below umbilical surgeries

Group BC received 0.75 ml/kg of 0.25% bupivacaine with 1 μg/ kg of clonidine in normal saline

Caudal block

Group B received 0.75 ml/kg of 0.25% bupivacaine in normal saline

Tripi, 2005

 

India

N: 18/ 17

Age (months) ± SD: 59.0 ± 30.4 /

67.6 ± 30.5

M:F: 2:16/ 5:12

Ureteroneocystostomy

1 ml/kg 0.125% bupivacaine with 1 µg/kg clonidine

Caudal block

preincision caudal block consisting of either 1 ml/kg 0.125% bupivacaine

Visoiu, 2021

 

USA

N: 26/ 24

Median age (years) (Q1,Q3): 13.0 (11.0, 15.0)/ 13.0 (11.5, 15.5)

%F: 46/ 54

 

Laparoscopic appendectomy

The R+C group received two 20 ml syringes with 10 ml of ropivacaine 0.5 % and 1 µg/kg of clonidine (100 µg =1 ml) for a total volume of 11 ml. Each patient in the R+C group received a total of 2 µg/kg clonidine.

Rectus sheath nerve block

The RO group received two 20 ml syringes, each with 10 ml of ropivacaine 0.5% and a 1 ml of normal saline

 

Results

  1. Postoperative pain

In the included studies different pain scales were used to assess postoperative pain. Table 2 includes the descriptions of these different scales.

 

Table 2. Different pain scales used to assess postoperative pain.

Name

Abbreviation

Scoring

Score range

Meaning

Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS)

CHEOPS

6 categories of pain behavior: Cry, facial, verbal, torso, touch, and legs

0 to 2 or 1 to 3 is assigned to each activity, total score range 4-13

higher scores indicating greater level of pain

Children and Infants Postoperative Pain Scale (CHIPPS) 

CHIPPS

4 items: crying, facial expression, trunk's posture, legs' posture and motor restlessness

0 to 2 points per item, total score range 0-8

higher scores indicating greater level of pain

FACES scale

-

five categories: crying, facial

expression, position of torso, position of legs and motor restlessness

Complication score 1, none; 2, moderate; 3, severe

higher scores indicating greater level of pain

FACES Pain Rating Scale (Wong-Baker)

-

6 faces; the first face represents a pain score of 0, and indicates "no hurt". The second face represents a pain score of 2, and indicates "hurts a little bit". The third face represents a pain score of 4, and indicates "hurts a little more". The fourth face represents a pain score of 6, and indicates "hurts even more"

0-6

higher scores indicating greater level of pain

Face, Legs, Activity, Cry, Consolability (FLACC) Behavioral Pain Scale

FLACC

5 categories: face, legs, activity, cry, and consolability

0 to 2 points per category, total score range 0-10

higher scores indicating greater level of pain

Numeric pain rating scale

NRS

0 being no pain and 10 the worst imaginable pain

0-10

higher scores indicating greater level of pain

Objective Pain Scale

OPS

4 pain behaviors: crying, movement, agitation, and verbalization 

0 to 2 points per category, total score range 0-10

 

higher scores indicating greater level of pain

Visual analog scale

VAS

A continuous scale ranging from no pain to worst pain

0 to 10

higher scores indicating greater level of pain

 

1.1. Postoperative pain at PACU arrival/ 0 hours

Nine studies reported on postoperative pain at PACU arrival or pain assessed at 0 hours. All studies used different measurement and reporting methods. Therefore, the results are described per study.

 

Anoar (2016) assessed pain using the CHEOPS and reported mean pain scores (± standard deviation, SD). The mean pain scores were 5.8 (± 0.9) and 6.4 (± 0.8) in the clonidine (n=20) and control group (n=20), respectively (MD -0.60, 95% CI -1.13 to -0.07). This difference is not clinically relevant.

 

Bhati (2022) used the OPS and reported only mean pain scores. The mean pain score was 0 for both the intervention (n=20) and control group (n=20), respectively (MD 0).

 

El-Hennway (2009) assessed pain with the FLACC and reported participant’s pain intensity in percentages per score. For the intervention group the distribution of the scores was as follows, score 0= 45%, score 1= 40%, score 2= 15%, and for the control group scores were 0 = 25%, score 1= 45%, score 2= 30%.

 

Joshi (2004) assessed with the FACES scale reported by a nurse and reported mean pain scores (±SD). A pain score of 6.7 (±1.5) in the intervention group (n=18) and a pain score of 6.8 (±1.7) the control group (n=17) was found (mean difference (MD) -0.10; 95 % CI -1.16 to 0.96). This difference is not clinically relevant.

 

Koul (2009) assessed pain with the OPS at 30 minutes, 1 hour and 2 hours and reported mean OPS scores (±SD) over these time-intervals. The mean pain scores were 4.65 (± 0.25) and 4.55 (± 0.25) in the intervention (n=20) and control group (n=20), respectively (MD - 0.10 95% CI -0.05 to 0.25). This difference is not clinically relevant.

 

Mostafa (2021) assessed pain using the CHEOPS and reported mean pain scores (±SD). The mean pain scores were 4.00 (± 0.1) and 4.10 (± 0.3) in the intervention (n=30) and control group (n=30), respectively (MD - 0.10 95% CI -0.47 to 0.27). This difference is not clinically relevant.

 

Potti (2017) assessed pain using the CHIPPS and authors reported the number of patients experiencing each score (Table 3).

 

Table 3. CHIPPS pain scores at 1 hour (Potti 2017).

CHIPPS score

0

1

2

3

≥4

I1: (n = 25) levobupivacaine 0.25% 1 mL/kg with 1 mug/kg clonidine caudally and 5 mL of normal saline i.v

25 (100%)

 

 

 

 

I2: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 1 mug/kg clonidine in 5 mL normal saline i.v

25 (100%)

 

 

 

 

C: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 5 mL of normal saline i.v

20 (80%)

3 (12%)

2 (8%)

 

 

 

Tripi (2005) assessed pain using the FACES Pain Rating Scale for children 1 to 3 years old, and

the FLACCS for children 4 years or older. Only mean values were reported; the mean pain scores were 0.90 and 1.18 in the intervention (n=18) and control group (n=17), respectively (MD -0.28). This difference is not clinically relevant.

 

Visoiu (2021) assessed pain using a NRS and reported mean pain scores (±SD). The mean pain scores were 1.20 (± 2.55) and 1.79 (± 2.78) in the intervention (n=25) and control group (n=19), respectively (MD -0.59, 95% CI -2.19 to 1.01). This difference is not clinically relevant.

 

1.2. Postoperative pain at 6 hours

Seven studies reported on postoperative pain at 6 hours. All studies used different measurement and reporting methods. Therefore, the results are described per study.

 

Anoar (2016) used the CHEOPS and reported mean pain scores (±SD). The mean pain scores were 4.5 (±0.5) and 6.2 (±1.1) in the intervention (n=20) and control group (n=20), respectively (MD -1.70, 95% CI -2.23 to -1.17). This difference is clinically relevant, in favor of clonidine.

 

Bhati (2022) used the OPS and reported only mean pain scores. The mean pain score was 0.75 versus 5 for the intervention (n=20) and control group (n=20), respectively (MD -4.25). This difference is clinically relevant, in favor of clonidine.

 

Jindal (2011) assessed pain with the FLACC and reported participant’s pain intensity in percentages per predefined score-ranges. For the intervention group (n=25) the distribution of the scores was as follows, 0-3 (no pain to mild pain) 24 (96%) 4-6 (moderate pain) 1 (4%); and for the control group (n=25) the scores were 0-3 (no pain to mild pain) 21 (84%) 4-6 (moderate pain) 3 (12%).

 

Narasimhamurthy (2016) assessed pain with the FLACC and reported number of patients with a score ≥ 4. Zero of 30 patients (0%) in the clonidine group; and 18 of 30 patients (60%) in the control group had a pain score ≥ 4. This difference in percentages is in favor of clonidine.

 

Parameswari (2010) assessed pain with the FLACC scale and reported results into categorized scores of four groups of pain severity (0 = No pain; 1 - 3 = Mild pain; 4 - 7 = Moderate pain; 8 - 10 = Severe pain). In the clonidine group, 33 of 50 patients (66%) had no to mild pain compared to 12 of 50 patients (24%) in the control group; and 17 patients (34%) in the clonidine group experienced moderate to severe pain compared to 38 patients (76%) in the control group. This difference in percentages in in favor of clonidine.

 

Potti (2017) assessed pain using the CHIPPS and reported the number of patients experiencing each score (Table 4). The difference between both clonidine groups and the control group is in favor of the clonidine groups.

 

Table 4. CHIPPS pain scores at 6 hours (Potti 2017).

CHIPPS score

0

1

2

3

≥4

I1: (n = 25) levobupivacaine 0.25% 1 mL/kg with 1 mug/kg clonidine caudally and 5 mL of normal saline i.v

6 (24%)

18 (72%)

1 (4%)

 

 

I2: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 1 mug/kg clonidine in 5 mL normal saline i.v

1 (4%)

5 (20%)

12 (48%)

4 (16%)

3 (12%)

C: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 5 mL of normal saline i.v

 

 

1 (4%)

 

24 (96%)

 

Visoiu (2021) assessed pain using a NRS and reported mean pain scores (±SD). The mean pain scores were 2.28 (± 2.49) and 2.43 (± 2.95) in the intervention (n=18) and control group (n=14), respectively (MD -0.15, 95% CI -2.08 to 1.78). This difference is not clinically relevant.

 

1.3. Postoperative pain at 24 hours

Seven studies reported on postoperative pain at 24 hours. All studies used different measurement and reporting methods. Therefore, the results are described per study.

 

Anoar (2016) used the CHEOPS and reported mean pain scores (±SD). The mean pain scores were 5.8 (± 0.9) and 7.7 (± 0.4) in the intervention (n=20) and control group (n=20), respectively (MD -1.90, 95% CI -2.33 to -1.47). This difference is clinically relevant.

 

Bajwa (2010) used the OPS and reported mean pain scores (±SD). The mean pain scores were 3.58 (± 0.40) and 3.72 (± 0.42) in the intervention (n=22) and control group (n=22), respectively (MD -0.14; 95% CI -0.38 to 0.10). This difference is not clinically relevant.

 

El-Hennway (2009) assessed pain with the FLACC and reported participant’s pain intensity in percentages per score. At 24 hours postoperatively, for the intervention group (n=30) the distribution of the scores was as follows, score 1 (30%), score 2 (40%), score 3 (30%), and for the control group (n=30) score 1 (40%), score 2 (40%), score 2 (20%).

 

Joshi (2004) assessed pain at 24 hours postoperatively based on parent reported visual analog scale (VAS) scores (0 representing no pain, and 10 representing worst imaginable pain) at rest and during movement. At rest, a pain score of 1.9 (±2.7) in the intervention group (n=18) and a pain score of 1.8 (±1.9) in the control group (n=17) was found (MD 0.10; 95 % CI -1.44 to 1.64).

This difference is not clinically relevant. During movement, a pain score of 3.6 (±3.3) in the intervention group (n=18) and a pain score of 3.2 (±2.3) the control group (n=17) was found (MD 0.40; 95 % CI -1.48 to 2.28). This difference is not clinically relevant.

 

Mostafa (2021) assessed pain using CHEOPS and reported mean pain scores (±SD). The mean pain scores were 4.13 (± 0.3) and 4.13 (± 0.3) in the intervention (n=30) and control group (n=30), respectively (MD 0.00, 95% CI -0.45 to 0.15). This difference is not clinically relevant.

 

Narasimhamurthy (2016) assessed pain with the FLACC scale and reported number of patients with a score ≥ 4. Three of 30 patients in the clonidine group (10%); and 2 of 30 patients in the control group (6.6%) had a pain score ≥ 4.

 

Potti (2017) assessed pain using the CHIPPS and reported the number of patients experiencing each score (Table 5).

 

Table 5. CHIPPS pain scores at 24 hours (Potti 2017)

CHIPPS score

0

1

2

3

≥4

I1: (n = 25) levobupivacaine 0.25% 1 mL/kg with 1 mug/kg clonidine caudally and 5 mL of normal saline i.v

 

1 (4%)

3 (12%)

1 (4%)

20 (80%)

I2: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 1 mug/kg clonidine in 5 mL normal saline i.v

 

 

1 (4%)

 

24 (96%)

C: (n = 25) levobupivacaine 0.25% 1 mL/kg caudally and 5 mL of normal saline i.v

 

 

 

 

25 (100%)

 

1.4. Reporting of postoperative pain with incomplete information

Ten other included studies did measure postoperative pain but only reported limited or unreadable data in the results section:

 

Akbas (2005) used the observational Oucher Pain Scale and only reported that there were no statistically significant differences among the groups with respect to the pain scoring.

 

Akin (2010) used the CHIPPS and presented results in a graph from which the data are not readable. The graph shows that the control group had higher pain scores during the first postoperative hour but were similar with the intervention group at 6h and 24h postoperatively.

 

De Mey (2000) used a VAS in children older than 5 years and CHEOPS in children less than 5 years of age, but no absolute pain scores are reported in the results section. The authors only report that the pain scores at 2, 6 and 12h postoperatively were not significantly different among the groups.

 

De Negri (2001) used the CHEOPS once in the recovery room and every 4h if the patient was awake, but only reported that pain scores were lower in the group receiving ropivacaine plus clonidine 0.12 mg compared to ropivacaine plus lower doses of clonidine (0.04 and 0.08 mg) and plain ropivacaine.

 

Ivani (2000) used the OPS and registered the mean of the maximum scores for each individual patient who did not require supplemental analgesia during the 24h study period. They report that OPS scores were similar between the control (mean: 1, range: 0–4; n=20) and the intervention (mean: 1, range: 0–4; n=20) groups (MD: 0).

 

Laha (2012) used the CHEOPS at PACU, 4h, 8h and 24h, and presented results in a graph from which the data are not readable. The graph shows that pain scores were (slightly) higher for the clonidine group compared to the control group - with pain scores increasing over time.

 

Rawat (2019) used the CHIPSS and presented results in a graph from which the data are not readable. The graph shows that pain scores are lower in the clonidine compared to the control group at 0, 6, and 12h after surgery.

 

Sanwatsarka (2017) used the FLACC scale and presented results in a graph from which the data are not readable. The authors report that: FLACC pain score never reached ≥4 during the first 3h after surgery in both groups; the number of patients with FLACC pain score ≥4 were significantly more in the control group at the end of 4th (46%), 8th (56%) and 12th (72%) hour postoperatively compared to the clonidine group; more children in the control group had moderate to severe pain at 4h, 8h and 12h postoperatively, compared to children in the clonidine group.

 

Shaikh (2015) used the FLACC scale and presented data in a graph from which the data are not readable. The graph shows at that the FLACC score begins at a score of 0 at 0h postoperatively for both groups; that the clonidine group has a much lower score compared to the control group at 4-8hr; and that at 24h postoperatively the clonidine group still has lower pain scores, but there is less difference with the control group.

 

Singh (2012) used the FLACC scale and presented results in a graph from which the data are not readable. In this study, efficacy of ketamine, fentanyl and clonidine were compared with a control group and the authors report that the FLACC pain score in the clonidine group was statistically significant lower compared to the other groups.

 

  1. Anxiety

Only one study (Visoiu, 2021) reported on the outcome anxiety. In children undergoing bilateral rectus sheath blocks for laparoscopic appendectomy surgery, they used the State-Trait Anxiety Inventory for Children (scores can range from 20 to 80, with higher scores correlating with greater anxiety) six hours after rectus sheath injections to score postoperative anxiety. The mean STAIC anxiety scores were 29.0 (26.0, 32.0) and 30.0 (27.0, 30.0) in the clonidine (n=23) and control group (n=18), respectively (MD -1 in favor of the clonidine group).

 

3.       Postoperative opioid consumption

3.1. Postoperative opioid consumption in PACU

Three studies reported on postoperative opioid consumption in PACU. All three studies used different reporting methods, which meant that the results could not be pooled, and the results are described per study. In the study by Anouar (2016) supplemental analgesia of intravenous nalbuphine increments of 0.2 µg/kg was provided if the CHEOPS pain score was >7. The authors reported that no patient in the intervention group (n=20) nor in the control group (n=20) needed nalbuphine [RD: 0; 95% CI -0.09 to 0.09]. This difference is not clinically relevant.

 

In the study by Joshi (2004) fentanyl was given if the child had observable moderate or severe pain based on the faces scale (compilation score ≥2; see postoperative pain section, Table 2). The dose of fentanyl was 0.6 (±0.4) µg/kg in the intervention group compared to 0.8 (± 0.5) µg/kg in the control group (MD -0.20, 95% CI -0.50 to 0.10). This difference is not clinically relevant.

 

In the study by Tripi (2005) only mean intravenous morphine requirements for rescue therapy were reported (no SD). The consumption of morphine in PACU was 0.02 mg/kg in the intervention group compared to 0.05 mg/kg in the control group (MD 0.03). This difference is clinically relevant in favor of the control group.

 

3.2. Postoperative opioid consumption in 24 hours

Two studies reported on postoperative opioid consumption in 24h. In the study by Joshi (2004) doses of tylenol/codeine were given by the parents if their child appeared to be in pain. The mean number of doses of tylenol/codeine at 24h was 2.6 (±1.4) in the intervention group compared to 2.8 (± 2.5) in the control group (MD 0.20, 95% CI -1.13 to 1.53). This difference is not clinically relevant.

 

Tripi (2005) only reported mean intravenous morphine requirements for rescue therapy at 24h were reported (no SD). The consumption of morphine at 24h was 0.1 mg/kg in the intervention group compared to 0.2 mg/kg in the control group (MD 0.1). This difference is clinically relevant in favor of the intervention group.

 

3.3. Postoperative opioid consumption in total postoperative period

Five studies reported on postoperative opioid consumption in total postoperative period. All studies used different reporting methods, which meant that the results could not be pooled, and the results are described per study.

 

In the study by Akin (2010) patients with a CHIPPS score ≥4 were given tramadol oral drops (2 mg/kg). The authors reported on the number of patients requiring tramadol in the first 24h postoperatively: 19 of 20 (95%) patients who received clonidine caudally (I1); 13 of 20 (65%) patients who received clonidine in normal saline (I2) and 17 of 20 (85%) patients who only received levobupivacaine (C) required the rescue analgesic (RR I1 vs C: 1.12; 95% CI 0.91 to 1.38; RR I2 vs C: 0.76; 95% CI 0.53 to 1.11).

 

In the study by De Negri (2001) each child was prescribed acetaminophen/codeine suppositories to be given by the nurse if patients had CHEOPS scores >9 on two consecutive assessments 5min apart during the 48h study period. No absolute values were presented in the results section, but the authors report that the median number of postoperative analgesic doses was 4.0 in the control group, 4.0 in the group receiving clonidine 0.04 mg, 1.0 in in the group receiving clonidine 0.08 mg, and 1.0 in the group receiving clonidine 0.04 mg.

 

In the study by Ivani (2000) a fixed combination paracetamol (350 mg)-codeine (15 mg) suppository was administered if the patient’s OPS score was >5. Fewer patients needed supplemental paracetamol-codeine suppositories during the 24-h study period in the intervention group (2 of 20; 10%) compared to the control group (9 of 20; 45%) (RR: 0.22; 95% CI 0.05 to 0.90).

 

In the study by Kalachi (2007) tramadol 1–2 mg/kg IV was used for rescue analgesia if the pain score was ≥30 mm on a 0-100 mm VAS. Need for rescue analgesic during the first 24h after surgery was reported as yes/no. In the clonidine group, 29 of 42 (69%) needed tramadol compared to 26 of 63 patients in the control group (RR 1.67, 95% CI 1.17 to 2.39).

 

In the study by Tripi (2005) total number of patients requiring mean intravenous morphine requirements for rescue therapy during the 24h study period was reported. Five of 18 patients (27.7%) in the clonidine group received no postoperative morphine, compared to 1 of 15 (6.7%) in the control group (RR 4.17, 95% CI 0.54 to 31.88).

 

4.       Adverse events

4.1. Apnea

Not reported.

 

4.2. Respiratory depression

Thirteen studies reported on the incidence of respiratory depression (a decrease in oxygen saturation <93%, requiring oxygen by face mask). Figure 1 shows that there is no difference in risk between the pooled clonidine group (n=335) and pooled control group (n=334) (RD 0.00, 95% CI -0.02 TO 0.02).

 

Figure 1: respiratory depression.

 

4.3. Hypotension

Ten studies reported incidence of hypotension (systolic blood pressure (SBP) <70 mm Hg). Figure 2 shows that there is no difference in risk between the pooled clonidine group (n=304) and pooled control group (n=324) (RD 0.03, 95% CI -0.00 to 0.07).

 

Figure 2: Hypotension.

 

4.4. Sedation

In total 20 studies reported on sedation levels. Eleven studies reported data that could be interpreted for (clinical) relevance (Table 6). The other studies (n=9) only reported limited information or unreadable data in the results section and are described below the table. All studies used different measurement and reporting methods. Therefore, the results are described per study.

 

Table 6. Sedation scores per study.

Study

Sedation scale

Time

Reporting 

Clonidine group

N

Control group

N

Outcome (MD, RD)

Clinically relevant?

Bawja (2010)

three-point scale (opening of eyes: 3 = spontaneously, 2 = to verbal command, 1 = to physical shaking, 0 =not arousable)

24 h time interval (10-min interval after

extubation and thereafter at intervals of 1, 2, 4, 6, 8,

12, 18 and 24 h)

Mean (±SD)

2.86 (± 0.52)

22

2.68 (± 0.56)

22

MD 0.18,

95% CI -0.14 to 0.50

No

Ivani (2000)

a four-point scale

[0 (alert)–3 (not arousable)]

Until the patients were once again alert as indicated by spontaneous eye opening

Mean (range)

mean: 1, range: 0–2

20

mean: 1, range: 0–1

20

MD 0

No

Jindal (2011)

University of Michigan sedation scale (UMSS) (0-3 score range)

At extubation (PACU)

% per sedation score [0:1:2:3]

24%, 48%, 24%, 4%

25

16%, 40%, 32%, 16%

25

Similar distribution

No

Koul (2009)

four-point sedation score (1: asleep, not arousable by verbal contact; 2: asleep, arousable by verbal contact; 3: drowsy not sleeping; 4: alert/aware)

30minutes, 1 hour and 4 hours after the operation

mean sedation scores over these time-intervals

2.8 (± 0.45)

20

2.83 (± 0.47)

20

MD -0.03

95% CI -0.32 to 0.26

No

Potti (2017)

Ramsay Sedation Score

1h, 6h, 12h

Mean (±SD)

PACU (1h)

I_B: 2.52 ± 0.51

I_C: 2.40 ± 0.50

 

6 hours

I_B:  2.00 ± 0.00

I_C: 2.00 ± 0.00

 

12 hours

I I_B: 2.00 ± 0.00

I_C: 2.00 ± 0.00

 

25

PACU (1h)

2.40 ± 0.50

 

6 hours

2.00 ± 0.00

 

24 hours

not reported

 

25

PACU (1h)

2.40 ± 0.50

 

6 hours

2.00 ± 0.00

 

 

 

Mostafa (2021)

five-point sedation score (1. awake and alert, 2. sleeping but easily arouses to voice or light touch, 3. Arouses to loud voice or shaking, 4. arouses with painful stimuli and 5. cannot be aroused)

After

the block

Mean (±SD)

1.33 (± 0.1)

30

1.17 (± 0.1)

30

MD 0.16,

95% CI 0.11 to 0.21

No

Narasimhamurthy (2016)

three-point sedation score (0- awake, 1- arousable by voice, 2- arousable to pain, 3- unarousable)

First 2 hours

Number of patients per score

Score = 0

22 of 30

 

Score = 1

8 of 30

30

Score = 0

22 of 30

 

Score =1

8 of 30

30

Score = 0

RD 0.00

95% CI -0.22 to 0.22

 

Score =1

RD 0.00

95% CI -0.22 to 0.22

No

Sanwatsarka (2017)

a four-point sedation score (1 Asleep, not arousable by verbal contact; 2 Asleep, arousable by verbal contact; 3 Drowsy not sleeping; 4 Alert/awake)

0,1,2,4,8,12h

Mean (±SD)

0h

1.88±0.2112

 

4h

3.08±0.2208

 

12h

3.72±0.4032

25

0h

2.84±0.2688

 

4h

3.8±0.32

 

12h

4±0.0

25

0h

MD -0.96

95% CI -1.09 to -0.83

 

4h

MD -0.72

95% CI -0.87 to -0.57

 

12h

MD -0.28

No

Tripi (2005)

5-point

sedation score ranging from 1 (asleep, no response to painful

stimulus) to 5 (crying, agitated or restless).

15-minute intervals in the PACU

Mean

Initial score

3.2

 

All scores

3.4

18

Initial score

3.0

 

All scores

3.4

17

Initial score

MD 0.2

 

All scores

MD 0

No

Visoiu (2021)

Sedation Level (0, 1, 2)

 

PACU

% of patients per score [0, 1, 2]

18%, 77%, 5%

26

19%, 76%, 5%

24

Similar distribution

No

MD= mean difference; PACU=post anesthesia care unit; RD=risk difference; SD=standard deviation

 

Akbas (2005) used a three-point score (1, awake; 2, asleep but arousable by verbal contact; 3, asleep and not arousable by verbal contact) and only reported that sedation scores were higher in the clonidine group for the first 1-h period after the operation compared to the control group.

 

Akin (2010) used the Ramsay Sedation Score (1, awake: agitated or restless or both; 2, awake: cooperative, oriented, and tranquil; 3, awake but responds to commands only; 4, asleep: brisk response to light glabellar tap or loud auditory stimulus), but the data were presented in a graph from which the data was not readable. The authors reported that the mean postoperative sedation score was higher in the group that received levobupivacaine + clonidine caudally at 30-, 60- and 240-min post procedure compared to the group that received only levobupivacaine (control) and the group that received levobupivacaine + clonidine i.v. but not at extubation, 15 and 120 min and 6, 12 and 24 h postoperatively.

 

Bhati (2022) used the Ramsay Sedation Score at PACU at arrival and then every hour, but only reported in the results section that the score was 3 at 60 minutes post-block and that all children were awake and alert 120 minutes post-block.

 

De Negri (2001) assessed the degree of sedation with a three-point sedation scale based on eye opening (0 5 eyes open spontaneously; 1 5 eyes open to speech; 2 5 eyes open in response to physical stimulation) in the recovery room and every 4 h if the patient was awake for 48 h study period and presented data in a figure that was not readable. It was only reported that no statistical difference was found among the different study groups.

 

Joshi (2004) sedation level was scored with 0 corresponding to ‘asleep’ and 10 corresponding to ‘awake’. In the results section no absolute values are reported, but author report “there was no difference between the groups with respect to sedation the night of surgery or the following morning.”

 

Kaaibachi (2005) using a three-point scale (0, alert; 1, asleep but easy arousable; 2, asleep but not easily arousable) to measure sedation. In the results section they only report that there was no significant difference in the sedation scores between both groups either in recovery room (sedation score 2, 5% in the clonidine group versus 48% in the control group) or during the first 6 h.

 

Rawat (2019) used the Ramsay Sedation Score and presented data in a (bar) graph from which the values are not readable. The graph shows that sedation scores are higher in the clonidine group compared to the control group over all time points (0, 2, 4, 6, 8, 10, 12 h post-surgery).

 

Shaikh (2015) used a sedation score 0-3 according to child’s alertness and arousability. Data were presented in a figure and not readable. Sedation scores up to 8 hours postoperatively were lower in the control group as compared to the clonidine group. At 8 hours, both groups had a sedation score of 0.

 

Singh (2012) assessed sedation by using a four-point sedation score (Patient sedation score was defined as 1: Asleep, not arousable by verbal contact 2: Asleep, arousable by verbal contact, 3: Drowsy, not sleeping, 4: Alert/ awake) at every hour for the first eight hours. Data presented in figure not readable and further not reported by the authors. From the figure it can be observed that the intervention group had higher sedation scores throughout all timepoints as compared to the control group.

 

4.5. Postoperative emergence delirium

Not reported.

 

Level of evidence of the literature

The level of evidence for all outcome measures started as high, since the included studies were RCTs.

 

The level of evidence regarding the outcome measure postoperative pain at PACU arrival/ 0 hours was downgraded by two levels to low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -1).

 

The level of evidence regarding the outcome measure postoperative pain at 6 hours was downgraded by two levels to low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -1).

 

The level of evidence regarding the outcome measure postoperative pain at 24 hours was downgraded by two levels to low because of study limitations (risk of bias); and number of included patients (imprecision, -1).

 

The level of evidence regarding the outcome measure anxiety was downgraded by three levels to very low because only one study with a limited number of included patients was included (imprecision, -3).

 

The level of evidence regarding the outcome measure postoperative opioid consumption in PACU was downgraded by three levels to very low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -2).

 

The level of evidence regarding the outcome measure postoperative opioid consumption in 24 hours was downgraded by three levels to very low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -2).

 

The level of evidence regarding the outcome measure postoperative opioid consumption in the total postoperative period was downgraded by three levels to very low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -2).

 

The level of evidence regarding the adverse events apnea and postoperative emergence delirium could not be assessed as no evidence was available.

 

The level of evidence regarding the adverse event respiratory depression was downgraded by one level to moderate because of study limitations (risk of bias, -1).

 

The level of evidence regarding the adverse event hypotension was downgraded by two levels to low because of study limitations (risk of bias, -1); and conflicting results (inconsistency, -1).

 

The level of evidence regarding the adverse event sedation was downgraded by two levels to low because of study limitations (risk of bias, -1); and number of included patients (imprecision, -1).

A systematic review of the literature was performed to answer the following question: What is the effect of adding an alpha-2-agonist (clonidine) to the locoregional block compared with not adding alpha-2-agonist to the locoregional block in children undergoing a surgical procedure?

P: Children undergoing a surgical procedure
I: Alpha-2-agonist (clonidine) + local anesthetic (ropivacaine or L-bupivacaine)
C: Local anesthetic (ropivacaine or L-bupivacaine)
O:

Postoperative pain

Anxiety

Postoperative opioid consumption

Adverse events

Relevant outcome measures

The guideline development group considered postoperative pain as a critical outcome measure for decision making; and anxiety, postoperative opioid consumption, complications and postoperative emergence delirium as important outcome measures for decision making.

 

The working group defined the outcome measures as follows:

  • Postoperative pain à PACU / 0 hours, 6 and 24 hours (at rest; if nothing was reported about the condition in which pain was assessed (at rest or during mobilization) it was assumed pain was measured at rest)
  •  A priori, the working group did not define the outcome measure 'anxiety' but used the definitions used in the studies.
  • Postoperative opioid consumption à morphine equivalent in PACU, at 24 hours and in total
  • Adverse events à apnea, respiratory depression, hypotension, sedation, postoperative emergence delirium

The working group defined one point as a minimal clinically (patient) important difference on a 10-point pain scale and 10 mm on a 100 mm pain scale. Regarding postoperative opioid consumption, a difference of 20% was considered clinically relevant. For dichotomous variables, a difference of 10% was considered clinically relevant (RR ≤0.91 or ≥1.10; RD 0.10).

 

Search and select (Methods)

The databases Medline (via OVID) and Embase (via Embase.com) were searched with relevant search terms until 12-2-2023 + 18-2-2023. The detailed search strategy is depicted under the tab Methods. The systematic literature search resulted in 419 unique hits. Studies were selected based on the following criteria;

 

Inclusion criteria:

  • Systematic review (SR) of randomized controlled trails (RCTs) or RCT
  • Published ≥ 2000
  • Children
  • Conform PICO

Exclusion criteria:

  • No original research
  • N≤10 per arm

A total of 86 studies (16 SRs, 70 RCTs) were initially selected based on title and abstract screening. After reading the full text, 61 studies were excluded (see the table with reasons for exclusion under the tab Methods), and 24 studies (all RCTs) were included.

 

Results

A total of 24 RCTs were included in the analysis of the literature. Important study characteristics and results are summarized in the evidence tables. The assessment of the risk of bias is summarized in the risk of bias tables.

  1. Akbas M, Akbas H, Yegin A, Sahin N, Titiz TA. Comparison of the effects of clonidine and ketamine added to ropivacaine on stress hormone levels and the duration of caudal analgesia. Paediatr Anaesth. 2005 Jul;15(7):580-5. doi: 10.1111/j.1460-9592.2005.01506.x. PMID: 15960642.
  2. Akin A, Ocalan S, Esmaoglu A, Boyaci A. The effects of caudal or intravenous clonidine on postoperative analgesia produced by caudal levobupivacaine in children. Paediatr Anaesth. 2010 Apr;20(4):350-5. doi: 10.1111/j.1460-9592.2010.03259.x. Epub 2010 Feb 11. PMID: 20158620.
  3. Anouar J, Mohamed S, Sofiene A, Jawhar Z, Sahar E, Kamel K. The analgesic effect of clonidine as an adjuvant in dorsal penile nerve block. Pan Afr Med J. 2016 Apr 21;23:213. doi: 10.11604/pamj.2016.23.213.5767. PMID: 27347302; PMCID: PMC4907766.
  4. Bajwa SJ, Kaur J, Bajwa SK, Bakshi G, Singh K, Panda A. Caudal ropivacaine-clonidine: A better post-operative analgesic approach. Indian J Anaesth. 2010 May;54(3):226-30. doi: 10.4103/0019-5049.65368. PMID: 20885869; PMCID: PMC2933481.
  5. Bhati K, Saini N, Aeron N, Dhawan S. A Comparative Study to Evaluate the Efficacy of Dexmedetomidine and Clonidine to Accentuate the Perioperative Analgesia of Caudal 0.25% Isobaric Levobupivacaine in Pediatric Infraumbilical Surgeries. Cureus. 2022 Aug 9;14(8):e27825. doi: 10.7759/cureus.27825. PMID: 36106237; PMCID: PMC9455914.
  6. de Mey JC, Strobbet J, Poelaert J, Hoebeke P, Mortier E. The influence of sufentanil and/or clonidine on the duration of analgesia after a caudal block for hypospadias repair surgery in children. Eur J Anaesthesiol. 2000 Jun;17(6):379-82. doi: 10.1046/j.1365-2346.2000.00690.x. PMID: 10928438.
  7. De Negri P, Ivani G, Visconti C, De Vivo P, Lonnqvist PA. The dose-response relationship for clonidine added to a postoperative continuous epidural infusion of ropivacaine in children. Anesth Analg. 2001 Jul;93(1):71-6. doi: 10.1097/00000539-200107000-00016. PMID: 11429342.
  8. El-Hennawy AM, Abd-Elwahab AM, Abd-Elmaksoud AM, El-Ozairy HS, Boulis SR. Addition of clonidine or dexmedetomidine to bupivacaine prolongs caudal analgesia in children. Br J Anaesth. 2009 Aug;103(2):268-74. doi: 10.1093/bja/aep159. Epub 2009 Jun 18. PMID: 19541679.
  9. Ivani G, De Negri P, Conio A, Amati M, Roero S, Giannone S, Lönnqvist PA. Ropivacaine-clonidine combination for caudal blockade in children. Acta Anaesthesiol Scand. 2000 Apr;44(4):446-9. doi: 10.1034/j.1399-6576.2000.440415.x. PMID: 10757579.
  10. Jindal P, Khurana G, Dvivedi S, Sharma JP. Intra and postoperative outcome of adding clonidine to bupivacaine in infraorbital nerve block for young children undergoing cleft lip surgery. Saudi J Anaesth. 2011 Jul;5(3):289-94. doi: 10.4103/1658-354X.84104. PMID: 21957409; PMCID: PMC3168347.
  11. Joshi W, Connelly NR, Freeman K, Reuben SS. Analgesic effect of clonidine added to bupivacaine 0.125% in paediatric caudal blockade. Paediatr Anaesth. 2004 Jun;14(6):483-6. doi: 10.1111/j.1460-9592.2004.01229.x. PMID: 15153211.
  12. Koul A, Pant D, Sood J. Caudal clonidine in day-care paediatric surgery. Indian J Anaesth. 2009 Aug;53(4):450-4. PMID: 20640207; PMCID: PMC2894500.
  13. Mostafa MF, Hamed E, Amin AH, Herdan R. Dexmedetomidine versus clonidine adjuvants to levobupivacaine for ultrasound-guided transversus abdominis plane block in paediatric laparoscopic orchiopexy: Randomized, double-blind study. Eur J Pain. 2021 Feb;25(2):497-507. doi: 10.1002/ejp.1689. Epub 2020 Nov 17. PMID: 33128801.
  14. Narasimhamurthy GC, Patel MD, Menezes Y, Gurushanth KN. Optimum Concentration of Caudal Ropivacaine & Clonidine - A Satisfactory Analgesic Solution for Paediatric Infraumbilical Surgery Pain. J Clin Diagn Res. 2016 Apr;10(4):UC14-7. doi: 10.7860/JCDR/2016/18946.7665. Epub 2016 Apr 1. PMID: 27190923; PMCID: PMC4866221.
  15. Parameswari A, Dhev AM, Vakamudi M. Efficacy of clonidine as an adjuvant to bupivacaine for caudal analgesia in children undergoing sub-umbilical surgery. Indian J Anaesth. 2010 Sep;54(5):458-63. doi: 10.4103/0019-5049.71047. PMID: 21189886; PMCID: PMC2991658.
  16. Potti LR, Bevinaguddaiah Y, Archana S, Pujari VS, Abloodu CM. Caudal Levobupivacaine Supplemented with Caudal or Intravenous Clonidine in Children Undergoing Infraumbilical Surgery: A Randomized, Prospective Double-blind Study. Anesth Essays Res. 2017 Jan-Mar;11(1):211-215. doi: 10.4103/0259-1162.200233. PMID: 28298787; PMCID: PMC5341679.
  17. Priolkar S, D'Souza SA. Efficacy and Safety of Clonidine as an Adjuvant to Bupivacaine for Caudal Analgesia in Paediatric Infra-Umbilical Surgeries. J Clin Diagn Res. 2016 Sep;10(9):UC13-UC16. doi: 10.7860/JCDR/2016/19404.8491. Epub 2016 Sep 1. PMID: 27790555; PMCID: PMC5072055.
  18. Rawat J, Shyam R, Kaushal D. A Comparative Study of Tramadol and Clonidine as an Additive to Levobupivacaine in Caudal Block in Pediatric Patients Undergoing Perineal Surgeries. Anesth Essays Res. 2019 Oct-Dec;13(4):620-624. doi: 10.4103/aer.AER_127_19. Epub 2019 Dec 16. PMID: 32009705; PMCID: PMC6937898.
  19. Sanwatsarkar S, Kapur S, Saxena D, Yadav G, Khan NN. Comparative study of caudal clonidine and midazolam added to bupivacaine during infra-umbilical surgeries in children. J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun;33(2):241-247. doi: 10.4103/0970-9185.209739. PMID: 28781453; PMCID: PMC5520600.
  20. Shaikh SI, Atlapure BB. Clonidine as an adjuvant for bupivacaine in caudal analgesia for sub-umbilical surgery: A prospective randomized double blind study. Anaesthesia, Pain & Intensive Care. 2019 Jan 27:240-6.
  21. Singh J, Shah RS, Vaidya N, Mahato PK, Shrestha S, Shrestha BL. Comparison of ketamine, fentanyl and clonidine as an adjuvant during bupivacaine caudal anaesthesia in paediatric patients. Kathmandu Univ Med J (KUMJ). 2012 Jul-Sep;10(39):25-9. doi: 10.3126/kumj.v10i3.8013. PMID: 23434957.
  22. Tripi PA, Palmer JS, Thomas S, Elder JS. Clonidine increases duration of bupivacaine caudal analgesia for ureteroneocystostomy: a double-blind prospective trial. J Urol. 2005 Sep;174(3):1081-3. doi: 10.1097/01.ju.0000169138.90628.b9. PMID: 16094063.
  23. Visoiu M, Scholz S, Malek MM, Carullo PC. The addition of clonidine to ropivacaine in rectus sheath nerve blocks for pediatric patients undergoing laparoscopic appendectomy: A double blinded randomized prospective study. J Clin Anesth. 2021 Aug;71:110254. doi: 10.1016/j.jclinane.2021.110254. Epub 2021 Mar 19. PMID: 33752119.

Evidence table for intervention studies (randomized controlled trials and non-randomized observational studies [cohort studies, case-control studies, case series])

 

Study reference

Study characteristics

Patient characteristics

Intervention (I)

Comparison / control (C)

 

Follow-up

Outcome measures and effect size

Comments

Akbas 2005

Type of study: RCT

 

Setting and country: Single-centre, Turkey

 

 

Funding and conflicts of interest: Not reported.

Inclusion criteria: ASA physical status I–II, age 2–12 years scheduled for inguinal hernia repair and circumcision were randomly allocated into three study groups

 

Exclusion criteria: Children for whom there was contraindication to caudal block were excluded from the study.

 

N total at baseline:

I: 25

C: 25

 

Important prognostic factors2:

Mean age (years) ± SD:

I: 6.08 ± 2.87

C: 5.64 ± 3.13

 

Weight; mean ± SD:

I: 20.34 ± 8.27
C: 18.96 ± 8.55

 

Groups comparable at baseline?

There were no significant differences among the three study groups with respect to age, weight or

duration of surgery.

ropivacaine 0.2% 0.75 mlÆkg)1

plus clonidine 1 lgÆkg) (group RC)*

received ropivacaine 0.2%, 0.75 mlÆkg) (group R)*

 

 

*Drugs were diluted in 0.9% saline (0.75 mlÆkg)1)

Length of follow-up:

POD1

 

Loss-to-follow-up:

Not reported.

 

Incomplete outcome data:

Not reported, data seems complete for both groups as indicated by n in all tables.

 

 

1.Postoperative pain

Oucher Pain Scale; scores greater than 60 were assessed as pain.

 

This is an observational pain scoring system using five criteria: crying, agitation, movement, posture and localization of pain. Each criterion scores 0–2 to give a total score of 0–10

 

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

“There were no statistically significant differences

among the groups with respect to Oucher’s Pain Scale and modified OPS”

 

3. Postoperative opioid consumption

Scores greater than 60 were

assessed as pain and this time was recorded and

supplementary analgesic given in the ward or in the

house by parents (paracetamol 15 mgÆkg)1 orally).

 

3.3. Total

Total number of analgesic requirement

I: 4
C: 6

 

4. Adverse events

4.2. Respiratory depression

decrease in SpO2 <95% requiring supplementary oxygen

 

No episode of SpO2 was detected.

 

I: 0
C: 0

 

4.3. Hypotension

 An intraoperative decrease in SBP of more

than 30% from preoperative values

 

Under a figure it was reported there were “no significant differences” in SBP. / “There were no incidents of hypotension”.

 

I: 0
C: 0

 

4.4. Sedation

A three-point sedation scale (1, awake; 2, asleep but arousable by verbal contact; 3, asleep and not arousable by verbal contact)

 

“sedation scores were higher in group RC for the first 1-h period after the operation than the other groups”

Study aim: to compare the analgesic

quality and duration of ropivacaine 0.2% with the addition of

clonidine (1 lgÆkg)1

) with that of ropivacaine 0.2% and the addition of

ketamine (0.5 mgÆkg)1

) to that of ropivacaine 0.2% and also compare

the postoperative cortisol, insulin and glucose concentrations,

sampled after induction and 1 h later following caudal administration

in children

Akin, 2010

Type of study: RCT

 

Setting and country: single-centre, Turkey

 

Funding and conflicts of interest: not reported

Inclusion criteria: children aged 2–8 , ASA I–II, undergoing elective

inguinal hernia repair or orchidopexy surgery

 

Exclusion criteria: contraindication to caudal block or the study drugs

 

N total at baseline:

I1: 20

12: 20

C: 20

 

Important prognostic factors2:

For example

age ± SD:

I1: 4.1 ± 2

12: 4.1 ± 2

C: 4.1 ± 2

 

Weight:

I1: 17.0 ± 4.6

12: 17.4 ± 6.5

C: 17.7 ± 5.3

 

Surgical duration (min):

I1: 34.4 ± 12.5

12: 27.0 ± 9.5

C: 32.8 ± 12.6

 

Groups comparable at baseline? Age,

weight and the duration of surgery were similar

among the three study groups

 

I1: Levobupivacaine 0.25% 0.75 mlÆkg)1 and 2 lgÆkg)1 clonidine caudally and 5 ml normal saline i.v. (Group L-Ccau)

 

I2: Levobupivacaine 0.25%, 0.75 mlÆkg)1 and 2 lgÆkg)1 clonidine in 5 ml normal saline i.v. (Group L-Civ)

Levobupivacaine 0.25% 0.75 mlÆkg)1 and 5 ml normal saline i.v (group L)

Length of follow-up:

24 h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported, data seems complete for both groups as indicated by n in all tables.

 

 

1.Postoperative pain

Children and

Infants Postoperative Pain Scale (CHIPPS)

 

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

Results provided in a figure not readable à control group higher pain scores first hour but similar at 6 hours and 24 hours.

 

3. Postoperative opioid consumption

Patients with a CHIPPS score ≥4 were given

Tramadol oral drops (2 mgÆkg)1)

 

3.3. Total

N requiring rescue analgesia in the first 24 h postoperatively

I1: 19 of 20

12: 13 of 20

C: 17 of 20

 

4. Adverse events

4.2. Respiratory depression

“no episodes of SpO2 was recorded.”

I: 0
C: 0

 

4.3. Hypotension

Hypotension was defined as a

20% decrease in systolic blood pressure when compared with baseline.

 

“No incidents of hypotension were seen in any of the children studied”

I: 0
C: 0

 

4.4. Sedation

Ramsay Sedation

Score

 

“The mean

postoperative sedation score was higher in Group LCcau at 30, 60 and 240 min in postprocedure compared to Groups L and L-Civ but not at extubation, 15 and 120 min and 6, 12 and 24 h (P < 0.05, Figure 3).”

Study aim: to compare the

effects of caudal and intravenous (i.v.) clonidine on

postoperative analgesia after caudal levobupivacaine for inguinal herniorrhaphy or orchidopexy

surgery

Anouar, 2016

Type of study: RCT, double-blind

 

Setting and country: single-centre, Tunisia

 

Funding and conflicts of interest:

Inclusion criteria: ASA I (American society of anesthesiologists) unpremedicated children, aged from 1 to 5 years (µg20 kg) and undergoing day-case male circumcision

 

Exclusion criteria: allergy to local anesthetic, genital malformation, past history of penile surgery, preoperative incident and additional surgical procedure other than circumcision

 

N total at baseline:

I: 20

C: 20

 

Important prognostic factors2:

Age (months); mean ± SD:

I: 30 ±3.12

C: 25.2 ± 5

 

Weight (kg); mean ± SD:

I: 14.5 ± 1.5

C: 12.8 ± 2.1

 

Surgery duration (min); mean ± SD:

I: 16 ± 2.4
C: 17 ± 1.8

 

Groups comparable at baseline? Demographic parameters were similar in both groups

0.1 ml/Kg of bupivacaine 0.5% with 1µg/kg of clonidine in each side (group 1)

0.1 ml/kg of bupivacaine 0.5 % with placebo in each side (group 2)

Length of follow-up:

POD1

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported, data seems complete for both groups as indicated by n in all tables.

 

 

1.Postoperative pain

CHEOPS pain score

1.1.    PACU/ 0-h

I: 5.8 ± 0.9
C: 6.4 ± 0.8

 

1.2. 6 hours

I: 4.5 ± 0.5
C: 6.2 ± 1.1

 

1.3. 24 hours

I: 5.8 ± 0.9
C: 7.7 ± 0.4

 

3. Postoperative opioid consumption

3.1. PACU

Supplemental analgesia of intravenous nalbuphine

increments of 0.2 µg/Kg was provided if the CHEOPS pain score was >7

 

“no patient needed Nalbuphine in PACU.”

 

3.2. 24 hours/ 3.3. total

At home,

patients received oral paracetamol at the dose of 15mg/kg

systematically and Ibuprophene was given if CHEOPS (Children's

Hospital of Eastern Ontario Pain Scale) was superior to 7.

 

Number of patients

I: 5
C: 12

Study aim: to improve the DPNB analgesic effect by the adjunction of

clonidine as an adjuvant to bupivacaine 0.5% in this block.

Bajwa, 2010

Type of study: RCT; double-blind study

 

Setting and country: Single-centre, India

 

Funding and conflicts of interest: source of support: Nil; conflict of interest: none declared.

Inclusion criteria: ASA-I children, 1–9 years of age, scheduled for elective lower abdominal surgery (hernia surgery)

 

Exclusion criteria: local infection at the caudal region, bleeding diathesis, pre-existing neurologic or obvious spinal diseases, and any congenital anomaly of the lower back

 

N total at baseline:

I: 22

C: 22

 

Important prognostic factors2:

For example

Age (years); mean ± SD (range):

I: 3.4 ± 1.42 (1–9)

C: 3.1 ± 1.68 (1–9)

 

Sex (M/F); mean ± SD:

I: 20/2

C: 21/1

 

Weight (kg); mean ± SD:

I: 13.92 ± 6.16

C: 13.12 ± 7.86

 

 

Groups comparable at baseline? No difference could be detected from the data of 44 children regarding the patient demographics; The demographic profile of the patients in group I and group II was comparable with regards to age, weight and height and on statistical analysis no significant difference was found.

 

Group II (n = 22) received 0.25% ropivacaine, 0.5 ml/kg, with an addition of 2 µg/kg clonidine via the caudal route*

Group I (n = 22) received 0.25% ropivacaine, 0.5 ml/kg*

 

*with a total volume being constant at 0.5 ml/kg in both the study groups

Length of follow-up:

24 h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported, data seems complete for both groups as indicated by n in all tables.

 

 

1.Postoperative pain

A modified objective pain scale (OPS) was employed to assess the post-operative pain and duration of analgesia which was based on behavioural objectives that included crying, facial expressions, position of legs, position of torso and generalized motor restlessness. A score of 0 was considered as excellent analgesia while a score of 10 signifies completely ineffective analgesia.

 

Pain was recorded at a 10-min interval after extubation and thereafter at intervals of 1, 2, 4, 6, 8, 12, 18 and 24 h

 

1.3. 24 hours

Mean ± SD

I: 3.58 ± 0.40
C: 3.72 ± 0.42

 

3. Postoperative opioid consumption

3.1. PACU

3.2. 24 hours

3.3. Total

 

Not reported; Children who had a pain score of more than 4 were administered 15 mg/ kg of oral syrup of paracetamol.

 

4. Adverse events

4.2. Respiratory depression

I: 0

C: 0

 

4.4. Sedation

(opening of eyes: 3 = spontaneously, 2 = to verbal command, 1 = to physical shaking, 0 =not arousable)

 

Mean ± SD

I: 2.86 ± 0.52
C: 2.68 ± 0.56

Study aim: to determine qualitative and quantitative aspects of caudal block, haemodynamic

effects, and post-operative pain relief of ropivacaine 0.25% versus ropivacaine 0.25% with clonidine

for lower abdominal surgeries in paediatric patients

Bhati 2022

Type of study: RCT, double-blind

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Inclusion criteria: American Society of Anaesthesiologists (ASA) physical status I, aged one to six years of both sexes, scheduled for infraumbilical elective surgery

 

Exclusion criteria: emergency surgery; known allergy to study drugs; known history of active renal, hepatic, respiratory, or cardiac disease; a history of seizures, neurological, or neuromuscular disorder; known or suspected coagulopathy, refusal, cutaneous local infection, or any congenital malformation.

 

N total at baseline:

I: 20

C: 20

 

Important prognostic factors2:

For example

age (years); mean ± SD:

I: 3.85 ± 1.39

C: 3.40 ± 1.31

 

Sex (%M):

I: 100%

C: 100%

 

Weight (kg):

I: 14.10 ± 2.77
C:
13.70 ± 4.03

 

Groups comparable at baseline? There was no statistically significant difference in the demographic profile of the patients, distribution of the type of procedure, and duration of surgery

group LC (n = 20) received caudal injection of 0.25% levobupivacaine at a dose of 1 mL/kg body weight with clonidine 0.5 µg/kg

group L (n = 20) received caudal injection of 0.25% levobupivacaine at a dose of 1 mL/kg body weight

Length of follow-up:

24h

 

Loss-to-follow-up:

Not after enrolment

 

Incomplete outcome data:

Intervention:

N (%)

Reasons (describe)

 

Control:

N (%)

Reasons (describe)

 

 

1.Postoperative pain

Hannallah pain scale

 

1.1.    PACU (arrival)

I: 0
C: 0

 

1.2.    6 hours

I: 0.75

C: 5

 

3. Postoperative opioid consumption

3.1. PACU

3.2. 24 hours

3.3. Total

 

Not reported; If the pain score was 4 or more, injection paracetamol 10 mg/kg was given as a rescue analgesic.

 

4. Adverse events

4.2. Respiratory depression

 

“No episodes of clinically significant postoperative complications such as nausea, vomiting, respiratory depression, urinary retention, and pruritis were observed in any of the patients.”

 

4.4. Sedation

Ramsay sedation scale; at PACU at arrival and then every hour

 

“Sedation score was 3 at 60 minutes post-block. All children were awake and alert 120 minutes post-block.”

Study aim: to compare the effect of dexmedetomidine and clonidine to accentuate the perioperative analgesia of 0.25% isobaric levobupivacaine in pediatric caudal anesthesia

De Mey, 2000

Type of study:

RCT (4 groups)

 

Setting and country: single centre, Belgium

 

Funding and conflicts of interest: not reported

Inclusion criteria: ASA class I or II boys, aged between 8 months and 13 years, admitted for hypospadias repair

 

Exclusion criteria:

 

N total at baseline:

Intervention: 30

Control: 30

 

Important prognostic factors2:

For example

Age (months) ± SD:

I: 39.1 ± 29.4

C: 38.3 ± 32.2

 

Weight:

I:  14.5 ± 5.6

C: 14.9 ± 6.9

 

Groups comparable at baseline? Age, weight, and duration of surgery were not significantly different in the four groups.

0.5 mL kg−1 bupivacaine 0.25% caudally + 1 μg kg−1 clonidine (group II)

0.5 mL kg−1 bupivacaine 0.25% caudally (group I)

Length of follow-up:

24 hours

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1.Postoperative pain

VAS (visual analog scale) in children older than 5 years and with CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) in children less than 5 years of age

 

No absolute values reported, authors report that “The pain scores at 2, 4, 6, 8 and 12 h postoperatively were not significantly different among the four groups.”

 

3. Postoperative opioid consumption

Not reported, only paracetamol requirement

Study aim: to evaluate whether the addition of clonidine, or sufentanil, or both, to a bupivacaine solution for a caudal block prolonged the period of analgesia after operation in children.

De Negri, 2001

Type of study: randomized, observer-blinded study.

 

Setting and country: single-centre, Italy

 

Funding and conflicts of interest: not reported

Inclusion criteria: boys (age 1–4 yr,

ASA physical status I) scheduled to undergo inpatient

hypospadias repair

 

Exclusion criteria: commonly accepted contraindications to

epidural blockade and a history of allergic reactions to

local anesthetics.

 

N total at baseline:

Intervention: 15/15/15

Control: 15

 

Important prognostic factors2:

For example

Age (mo) ± SD:

I1: 31 ±10

I2: 28±14

I3: 32 ±9

C: 28 ± 12

 

Weight (kg) ± SD :

I1: 14 ± 5

I2: 13 ± 6

I3: 13 ± 5

C: 13 ± 7

 

Groups comparable at baseline? The four

groups were similar with respect to age, weight,

ASA physical status, baseline blood pressure and

heart rate, and time to eye opening after anesthesia

 

I1: ropivacaine 0.08% 0.16 mg · kg21 · h21 plus

clonidine 0.04mg · kg21 · h21 (Group RC1)

 

I2: ropivacaine

0.08% 0.16 mg · kg21 · h21 plus clonidine 0.08

mg · kg21 · h21 (Group RC2)

 

I3: ropivacaine 0.08%

0.16 mg · kg21 · h21 plus clonidine 0.12 mg · kg21 · h21

(Group RC3)

plain ropivacaine 0.1% 0.2 mg · kg21 · h21

(Group R)

Length of follow-up: postoperative 48-h period

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Three subjects in Group R and two subjects in

Group RC1 were excluded from the study because

of inadequate epidural block or catheter dislocation,

thus leaving 55 patients for final analysis.

 

 

1.Postoperative pain

Children’s

Hospital of Eastern Ontario Pain Score (CHEOPS)

(lowest score, 4, no pain; highest score, 13, severe pain)

 

CHEOPS scores

were lower in Group RC3 than RC2 than RC1 than

R;

 

2.Postoperative opioid consumption

Each child was prescribed

acetaminophen/codeine suppositories (200 mg/5 mg,

Lonarid; Boehringher, Ingel, Italy) (19) to be given by the

nurse if patients had CHEOPS scores .9 on two consecutive assessments 5min apart

 

2.3. Total number of doses of supplemental postoperative analgesics median (95% CI)

 

I1: 4 (2,6)

I2: 1 (2,6)

I3: 1 (0,3)

C: 4 (0,3)

 

4. Adverse events

4.4. Sedation

Presented in a figure not readable. Sedation scores for the first 48 postoperative hours. No statistical difference was found among the different study groups. The two

peaks in postoperative sedation coincide with the first and second postoperative night.

Study aim: to identify the dose response

relationship and possible side effects of

clonidine when added to a postoperative continuous epidural infusion of ropivacaine in children.

El-Hennway, 2009

Type of study: double-blinded RCT

 

Setting and country: single-centre, Egypt

 

Funding and conflicts of interest: not reported

Inclusion criteria: ASA status I and II patients,

aged 6 months to 6 yr undergoing lower abdominal surgeries

 

Exclusion criteria: a history of developmental

delay or mental retardation, which could make observational pain intensity assessment difficult; a known or suspected coagulopathy; a known allergy to any of the study drugs; and any signs of infection at the site of the proposed caudal block.

 

N total at baseline:

Intervention: 30

Control:30

 

Important prognostic factors2:

For example

age  months (range):

I: 45 (6–69)

C: 43 (7–66)

 

Weight (kg) (SD):

I: 16 (4.9)

C: 15 (4.4)

 

Groups comparable at baseline? subject characteristics and intraoperative

clinical profile were comparable among the three study groups

Group

‘B’ received: bupivacaine 0.25% (1 ml kg21) with clonidine 2 mg kg21 in normal saline 1 ml

Group ‘C’ received:

bupivacaine 0.25% (1 ml kg21) with normal saline 1 ml

Length of follow-up:

24 h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

observational FLACC pain scale

with its 0–10 score range

1.1.    PACU

I: score 0 (45%), score 1 (40%), score 2 (15%)

C: score 0 (25%), score 1 (45%), score 2 (30%)

 

1.2.    6 hours

Not reported

 

1.3. 24 hours

I: score 1 (30%), score 2 (40%), score 3 (30%)

C: score 1 (40%), score 2 (40%), score 2 (20%)

 

4. Adverse events

4.2. Respiratory depression

None observed

 

4.3. Hypotension

None observed 

 

 

Study aim: to compare the analgesic effects and

side-effects of dexmedetomidine and clonidine added to bupivacaine in pediatric patients undergoing lower abdominal surgeries.

Ivani, 2000

Type of study: prospective, observer-blinded RCT

 

Setting and country: single centre, Italy

 

Funding and conflicts of interest: not reported

Inclusion criteria: ASA 1 children, 1–7 years

of age, scheduled for elective sub-umbilical surgery

 

Exclusion criteria:

Not reported

 

N total at baseline:

Intervention: 20

Control: 20

 

Important prognostic factors2:

For example

Age (years) (range) [median (range)}

I: 3 (1–7)

C: 3 (1–7)

 

Sex (M/F):

I: 16/4

C: 18/2

 

Weight (kg) [median, range]:

I: 16 (10–22)
C:
16 (10–21)

 

Groups comparable at baseline? No difference could be detected between the two

groups regarding patient demographics (Table 1), intraoperative

HR, NIBP, RR, ETCO2 and SpO2 or in the

duration of surgery

 

Group R0.1C received

a caudal block with 1 ml/kg of ropivacaine

0.1% (Naropin, AstraZeneca, So¨derta¨lje, Sweden) with

the addition of clonidine 2 mg/kg (Catapress 150 mg/

ml, Boehringer-Ingelheim, Mannheim, Germany)

Group R0.2 received a caudal

block with 1 ml/kg of ropivacaine 0.2% (Naropin, AstraZeneca,

So¨derta¨lje, Sweden)

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

modified

objective pain scale (OPS) score

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

The mean of the maximum OPS scores registered for each individual patient who did not require supplemental analgesia were similar between the R0.2 (1, range: 0–4) and the R0.1C (1, range: 0–4) groups (ns).

 

3. Postoperative opioid consumption

A fixed combination paracetamol

(350 mg)-codeine (15 mg) suppository (Citodon

Minor, AstraZeneca, So¨derta¨lje, Sweden), with the initial dosing based on paracetamol 40 mg/kg, was administered if the patient’s OPS score was >5.

 

3.1. PACU

Five patients

in the R0.2 group but no patients in the R0.1C group were given a paracetamol-codeine suppository within

3 h postoperatively.

3.2. 24 hours

3.3. Total

Significantly 2

 

 

4. Adverse events

4.4. Sedation [median, range]

four-point scale [0 (alert)–3

(not arousable)]

I: 1 (0–2)
C: 1 (0–1)

 

The duration of postoperative sedation was also found to be similar in the two groups (95 min; range 60–180 min and 90 min; range 60–190 min, in the R0.2 and R0.1C groups, respectively).

Study aim: to compare the analgesic efficacy

and adverse effects of clonidine and dexmedetomidine when combined with bupivacaine for caudal

analgesia in children undergoing infraumbilical surgeries

Jindal, 2011

Type of study: Prospective, randomized, double-blind study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: not reported

Inclusion criteria: American Society of

Anesthesiologists (ASA) physical status I and II children aged less than 2 years undergoing elective cleft lip repair under general anesthesia.

 

Exclusion criteria: Patients with local infection at the

site of injection of block, history suggestive of drug allergy, children with any systemic disease that compromises any

cardiovascular, respiratory or neurological function, any other congenital anomaly, patient with history of upper and

lower airway disease, coagulation disorders, and children with history of sleep apnea and in whom postoperative

ventilation may be required

 

N total at baseline:

Intervention: 25

Control: 25

 

Important prognostic factors2:

For example

Age (months) ± SD:

I: 8.48 ± 7.11

C: 7.92 ± 6.48

 

Sex (M:F):

I: 17:8

C: 19:6

 

Weight (kg) ± SD:

I: 6.67 ± 1.63
C:
6.69 ± 1.83

Groups comparable at baseline?

yes

clonidine from a 150

μg/ml ampoule was diluted and 1 μg/kg was drawn with a

tuberculin syringe and added to 0.5 ml of 0.5% bupivacaine;

the resulting mixture was reconstituted with saline to a

volume of 1 ml to maintain a bupivacaine concentration

of 0.25% (Group A; n = 25)

solution of 1 ml 0.25% bupivacaine solution was prepared

by adding 0.5 ml saline to 0.5 ml of 0.5% bupivacaine

(Group B; n = 25) by one of the authors, who was no

further involved in data collection and surgery

Length of follow-up:

12h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

There were no drop-outs in the study

because of the failed block.

 

1. Postoperative pain

Postoperative pain was assessed by a trained

postoperative nurse who was unaware of the drug given using Face, Legs, Activity, Cry, Consolability (FLACC) score

 

1.2. 6 hours

0-3 (no pain to mild pain) (%)

I: 24 (96)
C: 21 (84)

4-6 (moderate pain) (%)

I: 1 (4)
C: 3 (12)

 

7-10 (severe pain) (%)

I:: nil
C: nil

 

The qualitative pain relief was better with group A as at all times, and more patients in group A had lower scores.

 

3. Postoperative opioid consumption

Type of analgesia not reported.

 

Nineteen (76%) subjects did not require rescue

analgesia in group A up to 12 hours postoperatively, while

5(20%) subjects in group B did not require rescue drug

up to 12 hours.

 

4. Adverse events

4.4. Sedation

Sedation at extubation was assessed using University of Michigan sedation scale (UMSS)

 

Sedation score: 0:1:2:3

I: 6:12:6:1
C: 4:10:8:4

Study aim: To evaluate the efficacy of adding clonidine to bupivacaine in bilateral

infraorbital nerve block for hemodynamic changes, requirement of opioids, volatile agent,

and muscle relaxants intraoperatively and relief of pain postoperatively

Joshi, 2004

Type of study: RCT

 

Setting and country: single-centre, USA

 

Funding and conflicts of interest: not reported

Inclusion criteria: children

scheduled for elective surgery (unilateral hernia,

hydrocelectomy, or orchidopexy) by one of three

surgeons were enrolled in the study. Patients were eligible for participation if they were between

6 months and 6 years of age.

 

Exclusion criteria: known allergy or sensitivity to clonidine.

 

N total at baseline:

Intervention: 18

Control: 17

 

Important prognostic factors2:

For example

Age (months) ± SD:

I: 28 ± 22 (7–65)

C: 44 ± 31 (8–83)

 

Weight (kg)

I: 13 ± 4.7
C:
15 ± 6.1

Sex:

I: F 3 M 15

C: F 2 M 15

 

Groups comparable at baseline? The

groups did not differ significantly with respect to

sex, age, or weight (Table 1). PACU discharge time

also did not differ between the two groups (98 ± 40

in group C vs 104 ± 34 in group S).

 

The clonidine

group (group C) received 2 lgÆkg)1 of clonidine

(100 lgÆml)1) in addition to the bupivacaine.

The

saline group (group S) received an equal volume of

preservative-free normal saline.

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

1.1.    PACU

faces scale by nurse

I: 6.7 ± 1.5
C: 6.8 ± 1.7

 

1.3. 24 hours - rest

The VAS was bounded with 0 representing no pain, and 10 representing worst imaginable pain, rated by parent.

 

I: 1.9 ± 2.7
C: 1.8 ± 1.9

24 hours – movement

I: 3.6 ± 3.3

C: 3.2 ± 2.2

 

3. Postoperative opioid consumption

Fentanyl was given if the child had observable

moderate or severe pain based on a faces scale.

3.1. PACU

There were significantly more patients in the group S who required fentanyl in the PACU (four patients in group C vs nine patients in group S; P < 0.05).

 

The amount of fentanyl did not differ between the two groups (0.6 ± 0.4 lgÆkg)1 in clonidine

vs 0.8 ± 0.5 lgÆkg)1 in the group S).

 

3.2. 24 hours

The number of doses of

acetaminophen/codeine

 

I: 2.6 ± 1.4
C: 2.8 ± 2.0

 

4. Adverse events

4.4. Sedation -POD 1

Sedation level

was scored with 0 corresponding to ‘asleep’ and 10 corresponding to ‘awake’

 

no numbers reported, author report “There was no difference between the groups with respect to sedation the night of surgery or the following morning.”

Study aim: to

determine whether caudal clonidine added to caudal bupivacaine

would decrease pain in paediatric patients undergoing surgery.

Koul, 2009

Type of study: RCT

 

Setting and country: single centre, India

 

Funding and conflicts of interest: not reported

Inclusion criteria:

40ASAI children

between 1-10 years of age weighing 5-20 kg,

who were scheduled to undergo inguinal herniotomy as daycare cases

 

Exclusion criteria:

Children with any contraindication to caudal block or having

congenital heart disease were excluded from the study

 

N total at baseline:

Intervention: 20

Control: 20

 

Important prognostic factors2:

For example

age (years) ± SD:

I: 3.45±2.06

C: 3.28± 1.65

 

Weight (kg)

I: 14.58±4.40

C: 13.45±6.04

 

Groups comparable at baseline?

Mean age, weight, surgical and recovery time were comparable between two groups

0.75 ml.kg-1 of

0.25% bupivacaine with 2μg.kg-1 of clonidine (Group C)

Caudal epidural injection of either 0.75ml.kg-

1 of 0.25% bupivacaine (Group B)

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

OPS score (at 30

minutes, 1hour and 2hours)

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

(only mean reported)

Mean, SD

I: 4.55±0.25
C: 4.65± 0.25

 

4. Adverse events

4.2. Respiratory depression

decrease

of SpO2 less than 93% and required supplemental oxygen via mask

 

None of the children had SpO2value less than 95%.

 

4.4. Sedation

1: asleep,not arousable by verbal contact;

2: asleep, arousable by verbal contact; 3:

drowsy not sleeping;4: alert/aware (30minutes,

1hourand 4hours after the operation)

 

mean, SD

I: 2.83±0.47
C: 2.8± 0.45

Study aim: to examine the haemodynamic and respiratory effects of clonidine as an adjunct to bupivacaine caudal epidural analgesia and compare its analgesic efficacy with control group in which only bupivacaine was used, in paediatric day care procedures

Laha, 2012

Type of study: prospective, randomized, double‑blind

trial

 

Setting and country: single centre, India

 

Funding and conflicts of interest: Nil, none declared.

Inclusion criteria: ASA

grade I children, aged 2 to 11 years, weighing 5 to

30 kilograms, scheduled for lower abdominal, perineal, and

lower limb surgeries

 

Exclusion criteria: Patients

having cardiovascular, neurological diseases, coagulopathy,

infection or deformity of local site and where parents

refused to give consent were excluded from the study.

 

N total at baseline:

Intervention: 15

Control: 15

 

Important prognostic factors2:

For example

age (year) ± SD:

I: 4.8 (±2.6)

C: 4.7 (±2.6)

 

Weight (kg) ± SD:

I: 14.4 (±4.2)

C: 14.8 (±5.5)

 

Sex (M:F):

I: 11:4

C: 11:4

 

Groups comparable at baseline? Patients in the 2 groups were comparable regarding age,

weight, sex distribution, and duration of surgery

mixture of ropivacaine 0.2% (1 ml/kg) with clonidine 2 μg/kg (group B)

caudal injection of either plain ropivacaine 0.2% (1 ml/kg) (group A)

Length of follow-up:

24 hours

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

Children’s Hospital Eastern Ontario Pain Scale (CHEOPS) at 0 hour , 4 hours, 8 hours, 12 hours,

16 hours, 20 hours and24 hours

1.1.    PACU

1.2. 6 hours

1.3. 24 hours

 

Results are presented in a graph, from which the exact scores cannot be read. At PACU, 4 hours, 8 hours and 24 hours, pain scores were (slightly) higher for C compared to I – with pain scores increasing over time.

 

4. Adverse events

4.1. Apnea

4.2. Respiratory depression

4.3. Hypotension

4.4. Sedation

4.5. Postoperative emergence delirium

 

The 2 groups

did not vary in respect to sedation or other adverse effect.

Study aim: to compare the post-operative pain relieving quality of %%i%%071ropivacaine 0.2% and clonidine mixture%% to that of plain ropivacaine 0.2% following caudal administration in children.

 

Mostafa, 2021

Type of study: prospective randomized controlled, double-blind

study

 

Setting and country: single-centre, Egypt

 

Funding and conflicts of interest: funding: not reported; CI: All authors reported no conflict of interest.

Inclusion criteria: children scheduled for laparoscopic orchiopexy aged between 3 and 8 years old and in American Society of

Anesthesiologists (ASA) physical status grade I–II

 

Exclusion criteria: Patients whose parents refused to consent for the study, had a history of developmental delay or mental retardation (making

observational pain intensity assessment difficult), with an

allergy to the study drugs, bleeding diathesis, renal, hepatic, cardiac, respiratory or neurological diseases, had signs of infection

at the site of the block or sleep apnea that may warrant

postoperative ventilation

 

N total at baseline:

Intervention: 30

Control: 30

 

Important prognostic factors2:

For example

age (year) ± SD:

I: 5.68 ± 1.7

C: 5.37 ± 1.6

 

Weight (kg):

I: 19.27 ± 3.7

C: 18.78 ± 4.1

 

Groups comparable at baseline? The initial demographic

parameters of these participants demonstrated no statistically

significant differences in terms of age, body weight,

stature (height), ASA status, duration of surgery and anesthesia time among the three groups of the study.

 

levobupivacaine plus clonidine (group C, n = 30)

levobupivacaine plus normal saline (group

B, n = 30)

Length of follow-up:

24hr

 

Loss-to-follow-up:

I: 0
C: 0

 

Incomplete outcome data:

I: 0
C: 0

 

 

1. Postoperative pain

Children's Hospital of Eastern Ontario Pain Scale (Mcheops)

1.1. PACU

I: 4.00 ± 0.1
C: 4.10 ± 0.3

 

1.2. 6 hours

Not reported

 

Alternative outcomes:

4 hours

I: 4.07 ± 0.3
C:
6.57 ± 2.0

 

8 hours

I: 7.33 ± 1.8
C:
5.03 ± 1.5

 

1.3. 24 hours

I: 4.13 ± 0.3
C: 4.13 ± 0.3

 

3. Postoperative opioid consumption

Patients scored >5 with modified CHEOPS received rescue analgesia with 15 mg/kg of intravenous paracetamol (Perfalgan, Paracetamol 1,000 mg; UPSA Laboratories).

 

3.1. PACU

3.2. 24 hours (within first postoperative day) – number of doses

 

One dose

I: 23 (76.7%)
C: 14 (46.7%)

 

Two doses

I: 7 (23.3%)
C: 16 (53.3%)

 

3.3. Total analgesic dose/24 hr (mg)

I: 361.17 ± 127.9
C: 429.00 ± 164.5

 

 

4. Adverse events

4.4. Sedation

sedation

score described by Culebras et al. (1. awake and alert, 2. sleeping but easily arouses to voice or light touch, 3. arouses

to loud voice or shaking, 4. arouses with painful stimuli and 5. cannot be aroused; Culebras et al., 2001).

I: 1.33 ± 0.1
C: 1.17 ± 0.1

Study aim: We

hypothesized that dexmedetomidine or clonidine could improve the analgesic profile

of levobupivacaine to the same extent during TAP block in children.

Narasimhamurthy, 2016

Type of study:

 prospective, double-blind, randomized, controlled study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: not reported

Inclusion criteria:

 ASA 1 children between 2-10 years of age, of either sex, scheduled to undergo infraumbilical surgeries (circumcision, herniotomy and orchidopexy)

 

Exclusion criteria:

Not reported

 

N total at baseline:

Intervention: 30

Control: 30

 

Important prognostic factors2:

For example

age (years) ± SD:

I: 4.8 + 1.7

C: 4.7 + 1.7

 

Weight (kg):

I: 13.73 + 2.8
C:
13.43 + 3.14

 

Sex (M/F):

I: 25/5

C: 26/4

 

Groups comparable at baseline? Yes; the groups were comparable with respect to age, weight, sex and duration of surgery difference was found to be insignificant

 

Group B: Received mixture of 0.2% Ropivacaine and preservative free Clonidine 1μg/kg.

Group A: Received mixture of 0.2% Ropivacaine and normal saline.

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

FLACC; no of patients with pain score 4

1.1. PACU

Not reported

 

6 hours
I: 0
C: 18(60%)

 

1.3. 24 hours

I: 3(10%)
C: 2(6.6%)

 

3. Postoperative opioid consumption

Rescue medication was administered in the form of oral syrup of paracetamol 15mg/kg when the FLACC score was > 4.

 

3.1. PACU

3.2. 24 hours,

Number of rescue analgesic doses in 24 hours

 

One dose

I: 24
C: 4

 

Two doses

I: 6
C: 18

 

Three doses

I: 0
C: 8

 

4. Adverse events

4.2. Respiratory depression

I: 0
C: 0

 

4.4. Sedation in first two hours (n)

sedation score 0- awake, 1- arousable by voice, 2- arousable to pain, 3- unarousable.

 

Score = 0

I: 22
C: 22

Score = 1

I: 8
C: 8

Study aim:

 to show the optimum concentrations of Ropivacaine and Clonidine to maximize analgesia without side effects by evaluating its safety and efficacy.

Parameswari, 2010

Type of study: prospective,

randomised, controlled, double-blinded study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: Source of Support: Nil, Conflict of Interest: None declared

Inclusion criteria: ASA physical

status I – II, age one to three years, undergoing subumbilical

surgeries under general anesthesia (circumcision; orchidopexy; herniotomy)

 

Exclusion criteria: Children with sacral bone abnormalities, spina bifida,

coagulopathy and infection at the site of caudal injection

 

N total at baseline:

Intervention: 50

Control: 50

 

Important prognostic factors2:

age (months):

I: 19

C: 21

 

Sex (M/F):

I: 47/3

C: 47/3

 

Weight (kg):

I: 9
C:
10

 

Groups comparable at baseline? Analysis of patient results revealed no differences in

the demographic characteristics of the two groups

 

Bupivacaine with 1 μg/kg clonidine

Plain bupivacaine

Length of follow-up: 24 hours post-operatively

 

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome

 Not reported

 

 

1. Postoperative pain

FLACC scale; 0 = No pain

1 - 3 = Mild pain

4 - 7 = Moderate pain

8 - 10 = Severe pain

 

1.2. 6 hours – pain score 0-3 (no pain or mild pain), n (%)

I: 33 (66)

C: 12 (24)

 

pain score 4-10 (moderate to severe pain), n (%)

I: 17 (34)

C: 38 (76)

 

3. Postoperative opioid consumption

Rescue medication was administered when the FLACC score was ≥ 4. Paracetamol suppository was used as rescue

medicine with a loading dose of 40 mg/kg followed by 20 mg/kg every six hours.

 

3.2. 24 hours

 

0 doses

I: 2
C: 9

 

One dose

I: 29
C: 34

 

Two does

I: 15
C: 7

 

Three doses

I: 4
C: 0

 

More patients in Group A (Plain bupivacaine) needed two or three doses of rescue medicines compared to patients in Group B (Clonidine with

bupivacaine)

 

4. Adverse events

4.2. Respiratory depression

oxygen saturation less than 93%, requiring oxygen by face mask

I: 0
C: 0

 

4.3. Hypotension

systolic blood pressure less than 70 mm Hg

I: 0
C: 0

Study aim: to evaluate the efficacy of clonidine added to bupivacaine in prolonging the

analgesia produced by caudal bupivacaine in children undergoing sub-umbilical surgery

Potti, 2017

Type of study: double-blind controlled study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: not reported

Inclusion criteria: ASA I-II; elective infraumbilical surgeries 

 

Exclusion criteria: any contradiction for caudal epidural and the study drugs; administration of any analgesic in the past 24h

 

N total at baseline:

Intervention: 25

Control: 25

 

Important prognostic factors2:

Age (years) ± SD:

I_B: 4.7 ± 2

I_C: 4.6 ± 1

C_A: 4.32 ± 2

 

Weight (kg):

I_B: 14.2 ± 4.4

I_C: 13.7 ± 3.8

C_A: 13.7 ± 4.2

 

Groups comparable at baseline?

Yes

Group B (n = 25) received levobupivacaine 0.25% 1 mL/kg with 1 mug/kg clonidine caudally and 5 mL of normal saline i.v

 

Group C (n = 25) received levobupivacaine 0.25% 1 mL/kg caudally and 1 mug/kg clonidine in 5 mL normal saline i.v

Group A (n = 25) received levobupivacaine 0.25% 1 mL/kg caudally and 5 mL of normal saline i.v

 

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

CHIPPSS

1.1. PACU (1h)

I_B: 0=25

I_C: 0=25

C_A: 0=20; 1=3; 2=3; 3=0; ≥4=0

 

1.2.    6 hours

I_B: 0=6; 1=18; 2=1;

I_C: 0=1; 1=5; 2=12; 3=4; ≥4=3

C_A: 2=1; ≥4=24

 

1.3. 24 hours

I_B: 1=1; 2=3; 3=1; ≥4=20

I_C: 2=1; 4 ≥=24

C_A: 4 ≥=25

 

3. Postoperative opioid consumption

CHIPPS score ≥ 4, paracetamol 10 mg/kg i.v infusion over 10 min

3.1. PACU

3.2. 24 hours

3.3. Total

No of patients not required rescue analgesia

I_B: 5

I_C: 1

C_A: 0

 

4. Adverse events

4.2. Respiratory depression

I_B: 0

I_C: 0

C_A: 0

 

4.3. Hypotension

I_B: 0

I_C: 0

C_A: 0

 

4.4. Sedation

Ramsay sedation scale, mean ± SD:

 

1.1. PACU (1h)

I_B: 2.52 ± 0.51

I_C: 2.40 ± 0.50

C_A: 2.40 ± 0.50

 

1.3.    6 hours

I_B:  2.00 ± 0.00

I_C: 2.00 ± 0.00

C_A: 2.00 ± 0.00

 

1.3. 24 hours

I I_B: 2.00 ± 0.00

I_C: 2.00 ± 0.00

C_A: not reported

Study aim: to compare the effects of caudal an intravenous clonidine on postoperative analgesia produced by caudal levobupivacaine in children undergoing infraumbilical surgery

Priolkar, 2016

Type of study:

prospective, randomised, double-blind, controlled study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: none

Inclusion criteria:

 in 60 patients, over 18 months, from May 2010 to November 2011. They were between 1-10 years of age, of ASA Physical Status I, weighing 5-20 kg, scheduled to undergo infraumbilical operations in a tertiary hospital

 

Exclusion criteria:

 contraindication to caudal blockade, history of allergic reaction to Bupivacaine or Clonidine, ASA Physical Status > I and parental refusal.

 

N total at baseline:

Intervention: 30

Control:30

 

Important prognostic factors2:

For example

Age (years) ± SD:

I: 4.43+1.52

C: 4.63+1.73

 

 

Weight (kg) ± SD:

I:

13.10+3.48

 

C:

12.76+3.21

 

Groups comparable at baseline?

Yes

 

 

 Group: BC: Mixture of 1ml/kg of 0.125% Bupivacaine with preservative free Clonidine 1μ/kg.

 

 Group: B: 1ml/kg of 0.125% Bupivacaine solution.

Length of follow-up:

24 hours

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

3. Postoperative opioid consumption

Patients were given oral paracetamol syrup 15mg/kg body weight as rescue analgesic for a pain score of IV or V during the first 24 hours after surgery. Postoperative pain was assessed at the end of 2 hours and thereafter 2 hourly for 6 hours, then 4 hourly for 24 hours by the 5-point verbal pain score as follows [13].

I Asleep

II Awake but no pain.

III Mild pain (on touching area or movement)

IV Moderate pain (constantly cries or complains of pain)

V Severe pain (uncontrollable or excessive crying).

 

3.2. 24 hours

No. of patients receiving postoperative rescue analgesic during the first 24 hours after surgery, mean±SD

I: 1.9±0.48

C: 3.46±0.57

 

4. Adverse events

4.2. Respiratory depression

I: 0
C: 0

 

4.4. Sedation

Sedation score was assessed at 2 hours postoperative and then 2 hourly for 6 hours by the – 4-point patient sedation score (PPS) as follows [14]:

1) Asleep not arousable.

2) Asleep arousable by verbal contract.

3) Drowsy.

4) Alert Awake.

 

Number of patients

Score 4

I: 24
C:  26

 

Score 3

I: 5
C:  4

 

Score 2

I: 1
C: 0

Study aim: To evaluate the efficacy and side effects of caudal clonidine in a low dose of 1μg/kg combined with a low concentration of 0.125% solution of bupivacaine.

Rawat, 2019

Type of study: prospective, randomized, double-blind- controlled study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: not reported

Inclusion criteria: ASA I-II, +/- 20% ideal body weight and height. Planned for elective perineal surgeries

 

Exclusion criteria: parent’s refusal, contraindication for caudal block, and history of allergic reaction to levobupivacaine, clonidine, or tramadol

 

N total at baseline:

Intervention: 32

Control: 32

 

Important prognostic factors2:

Age (years) ± SD:

I: 4.14 ± 1.05

C:  4.16 ± 1.87

 

Sex (M/F):

I: 15/7

C: 14/8

 

Weight (kg) ± SD:

I: 11.64 ± 2.25

C: 12.37 ± 2.82

 

Groups comparable at baseline?

Yes

Group III – 0.25% levobupivacaine (1 mL.kg-1) with clonidine 1 mug.kg-1.

Group I - 0.25% levobupivacaine (1 mL.kg-1)

Length of follow-up:

12 h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

CHIPPS

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

Data presented in figure not readable. Trend is that pain scores are lower in group III compared to group I over all time points (0, 2, 4, 6, 8, 10, 12 H P.O.)

 

4. Adverse events

4.4. Sedation

Ramsay sedation score

 

Data presented in figure not readable. Trend is that sedation scores are higher in group III compared to group I over all time points (0, 2, 4, 6, 8, 10, 12 H P.O.)

Study aim: 

In this study, we compare the effects of tramadol and clonidine as an additive to levobupivacaine in caudal block in children undergoing perineal surgeries regarding hemodynamic changes, analgesic effects, and side effects.

 

Sanwatsarka, 2017

Type of study: prospective,

randomized, controlled, double-blinded study

 

Setting and country: single-center, India

 

Funding and conflicts of interest: Nil./ There are no conflicts of interest.

Inclusion criteria: American Society

of Anesthesiologists physical status I-II, age 1-7 years,

undergoing sub-umbilical surgeries under general anesthesia

 

Exclusion criteria: Children with local infection of the caudal area, history of

allergic reactions to local anesthetics, bleeding diathesis,

preexisting neurological or spinal diseases, mental retardation,

and neuromuscular disorders. Patients, in whom caudal anesthesia

failed or inadequate analgesia was present, were excluded

from study.

 

N total at baseline:

Intervention: 25

Control:25

 

Important prognostic factors2:

For example

Age (years) ± SD:

I: 6.28±1.21

C: 6.64±1.29

 

Weight (kg):

I: 15.48±3.34

C: 16.28±3.06

 

Sex (M/F):

I: 23:2

C: 22:3

 

Groups comparable at baseline? The study groups were comparable with respect to mean age,

weight, gender, duration, and type of surgery

 

Group BC received 1 ml/kg 0.25% bupivacaine + 1 μg/kg clonidine in normal saline

Group B received 1 ml/

kg 0.25% bupivacaine in normal saline

Length of follow-up:

24h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

FLACC pain score 1,2,3,4,8,12, 24 hrs

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

Data provided in a figure, not readable. The FLACC pain score never reached ≥4 during the first 3 h in any of the groups. However, the number of patients with FLACC pain score ≥4 were significantly more in Group B at the end of 4th (46%), 8th (56%) and 12th (72%) h compared to the other two groups. Furthermore at the end of 12th h, the number of patients with FLACC pain score ≥4 were significantly more in Group BM (40%) compared to Group BC (8%). More children in Group B had moderate to severe pain at 4 h, 8 h and 12 h postoperatively, compared to children in Group BC and Group BM.

 

3. Postoperative opioid consumption

In the PACU, the necessity for rescue medicine was decided by the pain score. Rescue medication was administered when

patients had score of ≥4 on at least 2 occasions or showed obvious signs of pain. Paracetamol suppository was used as

rescue medicine with a loading dose of 40 mg/kg followed by 20 mg/kg every 6 h.

3.1. PACU

3.2. 24 hours

3.3. Total

 

1 dose

I: 12%
C: 0%

2 doses

I: 84%
C: 40%

 

3 doses

I: 4%
C: 60%

 

4. Adverse events

4.2. Respiratory depression

A decrease in oxygen saturation <93%, requiring

oxygen by face mask

I: 1
C:0

 

4.3. Hypotension

Systolic blood pressure (SBP) <70 mm Hg

I: 0
C:0

 

4.4. Sedation

Four (4) point sedation score

1 Asleep, not arousable by verbal contact

2 Asleep, arousable by verbal contact

3 Drowsy not sleeping

4 Alert/awake

 

Measured 0,1,2,4,8,12h postoperatively

 

Mean score at 0h postoperatively

I: 1.88±0.2112
C: 2.84±0.2688

Mean score at 4h postoperatively

I: 3.08±0.2208
C: 3.8±0.32

Mean score at 12h postoperatively

I: 3.72±0.4032
C: 4±0.0

Study aim: to compare the intraoperative hemodynamics, postoperative analgesia, postoperative rescue analgesic requirement,

postoperative sedation and side-effects of clonidine and midazolam used as adjuvants to bupivacaine for caudal analgesia.

Shaikh, 2015

Type of study: prospective randomized double blind study

 

Setting and country: single-centre, India

 

Funding and conflicts of interest: funding not reported. Conflict of interest: none declared by the authors.

Inclusion criteria: age 1-12 years, ASA I/II; given IC; to undergo elective sub-umbilical, perineal and lower limb surgeries

 

Exclusion criteria: patients > 12 years, ASA > III, any contraindications to epidural anaesthesia

 

N total at baseline:

Intervention: 30

Control: 30

 

Important prognostic factors2:

For example

Age (months) ± SD:

I: 58.30 ± 27.92

C: 74.40 ± 37.34

 

Sex (M/F):

I: 27/3

C: 28/2

 

Weight (kg):

I: 14.67 ± 3.87

C: 14 ± 0.12

 

Groups comparable at baseline? yes

 

Group B received caudal 0.25% bupivacaine 1 ml/Kg with clonidine 1 μg/Kg as an adjuvant made to 0.5 ml with normal saline

Group A received caudal  0.25% bupivacaine plain with 0.5 ml Normal saline

Length of follow-up:

POD1

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

FLACC pain scale

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

Data presented in figure; values not readable. At 0 FLACC scale 0; at 4-8hr group B much lower score compared to group A; at 24 hours group B still lower, but less difference.

 

The score was 4 at 4 hrs in group A and at 12 hrs in group B.

 

3. Postoperative opioid consumption

FLACC ≥ 4; paracetamol 40 mg/kg

3.1. PACU

3.2. 24 hours

3.3. Total

 

One dose

I: 24
C: 2

 

Two doses

I: 6
C: 24

 

Three doses

I: 0
C: 4

 

4. Adverse events

4.2. Respiratory depression

I: 0
C: 0

 

4.3. Hypotension

I: 0
C: 1

 

4.4. Sedation

0-3 according to child’s alertness and arousability

 

Data presented in figure not readable. Sedation scores up to 8 hours postoperatively are lower in group A as compared to group B. at 8 hours, both groups score 0.

Study aim: to know the efficacy and safety of clonidine as an adjuvant to bupivacaine in single shot caudal block in children

Singh, 2012

Type of study: prospective randomized control trial

 

Setting and country: single-centre, Nepal

 

Funding and conflicts of interest: not reported

Inclusion criteria: Patients with ASA grade 1 and 2 coming for below umbilical surgeries that are under the age group age one to ten years weighing approximately between five to twenty kilograms

 

Exclusion criteria: Infection at the site of injection, bleeding disorders, patients who are on anticoagulant therapy, congenital anomalies of the spinal cord, congenital disorders, patients allergic to anesthetic drugs, surgeries extending more than 90 minutes, surgeries requiring anesthesia above T10 level, active CNS disorders and convulsive disorders.

 

N total at baseline:

Intervention: 20

Control: 20

 

Important prognostic factors2:

For example

Age (years) ± SD:

I: 5.45±2.5

C: 6.10±2.19

 

Weight (kg):

I: 14.70±3.8

C: 15.60±3.16

 

Groups comparable at baseline? All the four groups were comparable in relation to age and weight without any significant differences. Duration of anesthesia was also similar without any statistically significant differences.

 

Group BC received 0.75 ml/kg of 0.25% bupivacaine with 1 μg/ kg of clonidine in normal saline

Group B received 0.75 ml/kg of 0.25% bupivacaine in normal saline

Length of follow-up:

24 h

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Not reported

 

 

1. Postoperative pain

Pain score was evaluated using objective pain score scale by a trained nurse for 24 hours or till discharge (FLACC scale)

1.1. PACU

1.2. 6 hours

1.3. 24 hours

 

Data presented in figure not readable. Authors report “The pain score assessed using FLACC scale was compared between the four groups, and children in Group BC had lower pain scores, which was statistically significant(p<0.05)”.

 

3. Postoperative opioid consumption

If the score is more than 4 or if the patient complains of pain they were given oral paracetamol 10 mg/kg as rescue analgesia in the form of syrup/drops.

3.1. PACU

3.2. 24 hours

3.3. Total

 

“The requirement of rescue medicine was lesser in Group BC. Clonidine in a dose of 1 mcg/kg added to 0.25% bupivacaine for caudal analgesia, during sub-umbilical surgeries, prolongs the duration of analgesia of bupivacaine, without any side effects.”

 

4. Adverse events

4.2. Respiratory depression

Respiratory depression was considered if oxygen saturation less than 93% on breathing room air and if so supplemental oxygen via face mask was used at 4 liters per minute.

 

I: 0

C: 0

 

4.3. Hypotension

Intra-operative or post-operative decrease in systolic blood pressure and heart rate more than 30% of the baseline values were considered as severe hypotension and bradycardia respectively.

 

I: 0

C: 0

 

4.4. Sedation

Sedation was assessed by using sedation score. Assessment of sedation was done by sedation score at every hour for the first eight hours. Patient sedation score was defined as 1: Asleep, not arousable by verbal contact 2: Asleep, arousable by verbal contact, 3: Drowsy, not sleeping, 4: Alert/ awake.

 

Data presented in figure not readable and further not reported by the authors. From the figure it can be observed that the intervention group had higher sedation scores throughout all timepoints as compared to the control group.

Study aim:  To compare the efficacy of ketamine, fentanyl and clonidine in terms of quality and duration of analgesia they produce when added with caudal bupivacaine by single shot technique in children

Tripi, 2005

Type of study: RCT

 

Setting and country: single-centre, USA

 

Funding and conflicts of interest: not reported

Inclusion criteria: children 1 to

10 years old meeting American Society of Anesthesiologists

physical status classification I or II and undergoing ureteroneocystostomy.

 

Exclusion criteria:

not reported

 

N total at baseline:

Intervention: 18

Control: 17

 

Important prognostic factors2:

For example

age (months) ± SD:

I: 59.0 ± 30.4

C: 67.6 ± 30.5

 

Sex, no females (%):

I: 16 (89)

C: 12 (80)

 

Groups comparable at baseline? The 2 study groups were similar for mean age, weight and length of surgical procedure.

 

1 ml/kg

0.125% bupivacaine with 1 _g/kg clonidine

 

Caudal solutions also contained

1:400,000 epinephrine

preincision caudal block consisting of either 1 ml/kg 0.125% bupivacaine

 

Caudal solutions also contained

1:400,000 epinephrine

Length of follow-up:

24 hr

 

Loss-to-follow-up:

Not reported

 

Incomplete outcome data:

Two patients in the control group were excluded because of protocol violation.

 

 

1. Postoperative pain

Pain was measured using the Wong-Baker FACES Pain Rating Scale for children 1 to 3 years old, and the Faces, Legs, Activity, Cry and Consolability Scale for

children 4 years or older. With both scales a score of zero is considered no pain, and a score of 10 is considered worst possible pain.

1.1. PACU

I: 0.90
C: 1.18

 

1.2. 6 hours

1.3. 24 hours

 

Pain scores were measured at 15-minute intervals in the PACU and at 4-hour intervals on the postoperative ward until 24 hours postoperatively. à but data are not reported for last measures.

 

3. Postoperative opioid consumption

Intravenous morphine requirements for rescue therapy

 

3.1. PACU

I: 0.02 mg/kg

C: 0.05 mg/kg

 

3.2. 24 hours

I: 0.1 mg/kg

C: 0.2 mg/kg,

 

3.3. Total

Five of 18 patients in the clonidine-bupivacaine group received no postoperative morphine, compared to 1 of 15 in the bupivacaine group.

 

4. Adverse events

4.2. Respiratory depression

I: 0

C: 0

 

4.3. Hypotension

I: 0

C: 0

 

4.4. Sedation

Sedation was measured using a 5-point sedation score ranging from 1 (asleep, no response to painful stimulus) to 5 (crying, agitated or restless).

 

Mean initial sedation score was 3.2 for the treatment group and 3.0 for controls and mean of all PACU sedation scores was 3.4 for both groups.

Study aim: We evaluated whether clonidine, when added to bupivacaine, would significantly prolong caudal analgesia and decrease opioid requirements in children undergoing ureteroneocystostomy.

 

No absolute data were reported. Only in the text the mean values.

Visoiu, 2021

Type of study:

 randomized, double-blinded prospective study.

 

Setting and country:

 single center, USA

 

Funding and conflicts of interest: This work was supported by an educational seed grant from University of Pittsburgh Department of Anesthesiology and Perioperative Medicine. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Inclusion criteria: 10-17 years of age, weighed ≥34kg, and were scheduled for laparoscopic appendectomy during routine weekday hours

 

Exclusion criteria: Patients were excluded if they were <10 or ≥18 years of age, weighed < 34 or ≥100 kg, or had pre-existing cognitive impairment, developmental delay, chronic pain, and history of known allergies to medications used in the study or evidence of local infection at planned injection sites.

 

N total at baseline:

Intervention: 26, in final analysis 20

Control: 24, in final analysis 17

 

Important prognostic factors2:

Median age (Q1, Q3)

I: 13.0 (11.0, 15.0)

C: 13.0 (11.5, 15.5)

 

Sex, female %:

I: 46%

C: 54%

 

Median weight (kg) (Q1, Q3)

I: 53.9 (42.1, 63.0)

C: 56.3 (48.2, 66.2)

 

Groups comparable at baseline?

Yes

The R+C group received two 20 ml syringes with 10 ml of ropivacaine 0.5 % and 1 mcg/kg of clonidine (100 mcg =1 ml) for a total volume of 11 ml. Each patient in the R+C group received a total of 2 mcg/kg clonidine.

The RO group received two 20 ml syringes, each with 10 ml of ropivacaine 0.5% and a 1ml of normal saline (NS)

Length of follow-up:

 

 

Loss-to-follow-up:

Intervention: 0

Control: 0

 

Incomplete outcome data:

Intervention: 6

Missing periumilical numbness

Control: 7

Missing periumilical numbness

 

 

1. Postoperative pain

umbilical pain severity using the Numerical Pain Rating Scale (NPRS) (0 being no pain and 10 the worst imaginable pain). NPRS scores assessed every two hours from time of nerve block procedure.

1.1. PACU

I (n=25): 1.20 (2.55)
C (n=19): 1.79 (2.78)

 

1.2. 6 hours

I (n=18): 2.28 (2.49)
C (n=14): 2.43 (2.95)

 

2. Anxiety

STAIC anxiety scores

I (n=23): 29.0 (26.0, 32.0)
C (n=18): 30.0 (27.0, 30.0)

 

3. Postoperative opioid consumption

3.3. Total - Total Morphine Equivalents (mg/kg) perioperative

I (n=24): 0.20 (0.17, 0.24)
C (n=21): 0.22 (0.15, 0.36)

 

4. Adverse events

4.4. Sedation

PACU Sedation Level (0, 1, 2)

I (n=26): 18%, 77%, 5%
C (n=24): 19%, 76%, 5%

 

 

Study aim:

The primary aim of this study was to determine if the combination of ropivacaine plus clonidine in ultrasound (US)-guided rectus sheath nerve blocks was superior in prolonging periumbilical numbness compared to ropivacaine alone. Secondary aims included advancing the understanding of clonidine’s effect on perioperative analgesia, sedation, anxiolysis, and hemodynamics when used as an adjuvant in rectus sheath nerve blocks.

 

Study reference

(first author, publication year)

Was the allocation sequence adequately generated?

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Was the allocation adequately concealed?

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Blinding: Was knowledge of the allocated

interventions adequately prevented?

Were patients blinded?

Were healthcare providers blinded?

Were data collectors blinded?

Were outcome assessors blinded?

Were data analysts blinded?

Was loss to follow-up (missing outcome data) infrequent?

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Are reports of the study free of selective outcome reporting?

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Was the study apparently free of other problems that could put it at a risk of bias?

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Overall risk of bias

If applicable/necessary, per outcome measure

 

 

 

 

 

 

LOW

Some concerns

HIGH

Akbas 2005

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably yes

 

Reason: Drugs were diluted in 0.9% saline

(0.75 mlÆkg) and prepared by a staff anesthesiologist not otherwise involved in the study.

Probably yes

 

Reason: not reported, complete outcome data for 25 included patients per arm.

Probably yes

 

Reason: All relevant outcomes were reported, but no absolute data were reported for all outcomes.

Probably yes

 

Reason: funding and conflicts not reported.

High

 

Reason: allocation, randomization and blinding

Akin 2010

Probably no

 

Reason: not reported

Probably yes

 

Reason: Children were randomized, using a sealed envelope technique, to one of the three treatment groups before caudal block was performed

Probably yes

 

Reason: The study drug was prepared by an investigator unaware of the group assignment.

Probably yes

 

Reason: not reported, complete outcome data for 25 included patients per arm.

Probably yes

 

Reason: All relevant outcomes were reported, but no absolute data were reported for all outcomes.

Probably yes

 

Reason: funding and conflicts not reported.

High

 

Reason: allocation, blinding

Anouar 2016

Probably no

 

Reason: not reported

Probably yes

 

Reason: Each patient was randomly assigned to one of the two groups by drawing from a sealed envelope

Probably yes

 

Reason: double-blind study. After surgery, patients were observed in PACU (Post Anesthesia Care Unit) for 6 hours by a nurse blinded to the study.

Probably yes

 

Reason: not reported, complete outcome data for 25 included patients per arm.

Probably yes

 

Reason: All relevant outcomes were reported, but no absolute data were reported for all outcomes.

Probably yes

 

Reason: funding and conflicts not reported.

Some concerns

 

 

Reason: allocation

Bajwa 2010

Definitely yes

 

Reason: patients were randomly allocated according to a computer generated randomization

Probably no

 

Reason: not reported

Probably yes

 

Reason: double-blind study. The syringes for the study solutions were prepared by a senior resident of the anesthesiology department who was given written protocols for drug preparation and was unaware of the patients and operation theatre team.

Probably yes

 

Reason: not reported, complete outcome data for 25 included patients per arm.

Probably yes

 

Reason: All relevant outcomes were reported, but no absolute data were reported for all outcomes.

Definitely yes

 

Reason: No other problems noted

Some concerns

 

Reason: allocation

Bhati 2022

Definitely yes

 

Reason: Children enlisted for the study were randomly allocated into three groups using a computer-generated randomization chart

Probably no

 

Reason: not reported

Definitely yes

 

Reason: double-blind study. The volume of each local anesthetic solution was prepared by one anesthetist in a coded transparent 10 mL syringe and labeled with the patient’s study number. All healthcare personnel, parents and guardians, and the anesthetist who performed the block were blinded to the caudal medications administered.

Definitely no

 

Reason: consort diagram (figure 1) shows there were no dropouts, all patients were followed up till 24 hours.

Probably yes

 

Reason: all relevant outcomes were reported, but mainly descriptive

Definitely yes

 

Reason: No other problems noted

Some concerns

 

Reason: Allocation, reporting of results

De Negri 2001

Probably no

 

Reason: it is only stated that patients were randomly allocated into 2 equal groups

Probably no

 

Reason: not reported

Definitely no

 

Reason: Randomized, observer-blinded study. Assessments of the variables studied were recorded by nurse observers unaware of the mixture used for epidural infusions.

Probably no

 

Reason: not reported

Probably yes

 

Reason: All relevant outcomes were reported, but no absolute data were reported for all outcomes.

Definitely yes

 

Reason: No other problems noted

High

 

Reason: blinding, allocation and reporting of results

El-Hennway 2009

Definitely yes

 

Reason: Using a computer-generated list, the subjects were randomly

and evenly assigned into three groups: A, B, and

C.

 

Probably no

 

Reason: not reported

Definitely yes

 

Reason: All health-care personnel providing direct patient care, the subjects, and their parents or guardians were blinded to the caudal medications administered. All medications were prepared by pharmacy staff not participating in the

study except for preparing the drugs. They received and

kept the computer-generated table of random numbers

according to which random group assignment was performed. After obtaining subjects weight, and according to the randomizing table, the volume to be injected in the

caudal block was prepared in syringes with labels indicating

only the serial number of the patient.

Definitely no

 

Reason: 60 patients were enrolled into the study and none of the 60 attempted caudal blocks was perceived as being a failed attempt

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not readable

Definitely yes

 

Reason: No other problems noted

Some concerns

 

Reason: allocation

Ivani 2001

Definitely yes

 

Reason: Computer generated randomization was used to divide the patients

Probably no

 

Reason: not reported

Definitely no

 

Reason: observer-blinded study. Observers unaware of which drug had been administered evaluated the onset of the block and duration of postoperative analgesia.

Probably no

 

Reason: 40 patients were enrolled and loss-to follow up is not reported, but results show no missing data

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not readable

Definitely yes

 

Reason: No other problems noted

Some concerns

 

Reason: Allocation and lack of blinding

Jindal 2011

Definitely yes

 

Reason: For randomization, computer generated

numbers equal to the number of patients who

were scheduled for the study was put into serially labelled opaque sealed envelopes. Before surgery, an envelope

containing the random number was drawn for each patient.

Definitely yes

 

Reason: See text in left column

Probably no

 

Reason: It is only reported that the patient,

anesthesiologist who performed the block, and surgeon were blinded to which anesthetic agent would be used.

Probably no

 

Reason: 50 patients were enrolled and loss-to follow up is not reported, but results show no missing data

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Definitely yes

 

Reason: No other problems noted

Some concerns

 

Reason: lack of  blinding

Joshi 2004

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably no

 

Reason: It is only reported that a nurse blinded to group assignment treated postoperative pain.

Probably no

 

Reason: 36 patients were enrolled and loss-to follow up is not reported, but results show no missing data

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

High

 

Reason: allocation, blinding, outcome reporting

Koul 2009

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably no

 

Reason: it is reported this was a double-blind study, but no further information is provided on allocation and blinding.

Probably no

 

Reason: it is not reported how many patients were enrolled and whether there was loss to follow-up.

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

High

 

Reason: allocation, blinding, follow-up

Laha, 2012

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably no

 

Reason: it is reported this was a double-blind study, but no further information is provided on allocation and blinding.

Probably no

 

Reason: it is not reported how many patients were enrolled and whether there was loss to follow-up.

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

High

 

Reason: allocation, blinding, follow-up

Mostafa, 2021

Probably yes

 

Reason: randomization computer-

generated table using Microsoft Excel by a statistician who did not participate in the patients’ management

Probably yes

 

Reason: not reported

Probably yes

 

Reason: double blind study; the trial

was planned that neither the investigators (surgeons and anesthesiologists)

nor the patients’ guardians were aware of the group allocation and the drug combination received. An independent investigator who was not involved in performing the TAP block, or engaged with patient monitoring and

data collection was entrusted with preparing and administering the study drugs.

Definitely no

 

Reason: CONSORT flow diagram

Definitely yes

 

Reason: all (mean) data of relevant outcome measures provided

Reason: No other problems noted

Low

Narasimhamurthy 2016

Probably yes

 

Reason: randomization method is not reported

 

Probably yes

 

Reason: the patients were randomly allocated into two groups.

Probably yes

 

Reason: The attending anesthesiologist administered the

appropriate drug according to the code in the envelope. Name, age, hospital number, diagnosis and procedure were written in the same envelope, sealed and handed over to the investigator at the end of the procedure. A second observer did the patient assessment and data collection. The anesthesiologist who was collecting the data was blinded to the contents of the study drug. After all the cases had been completed at the end of the study, the code was broken, study drug contents revealed, and data compiled.

Probably no

 

Reason: not reported

Probably yes

 

Reason: all (mean) data of relevant outcome measures provided

Reason: No other problems noted

Some concerns

 

Reason: randomization method

Parameswari 2010

Probably no

 

Reason: Randomization was done by picking random lots from a sealed bag

Probably no

 

Reason: not reported

Probably no

 

Reason: The drug was loaded by an anesthesiologist

who did not participate in the study. Post-operative assessment was done by another anesthesiologist in the PACU who was not aware of the drug administered and by a nurse in the ward who was also blinded.

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

Some concerns

 

Reason: allocation and blinding

Potti 2017

Probably yes

 

Reason: patients were randomly allocated to one of the three groups by a computer-generated list and delivered in opaque, sealed numbered envelopes.

Probably yes

 

Reason: see text in left column

Probably no

 

Reason: double blind study, anesthesiologist who performed blocks was blinded to study drug, no further information stated

 

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

Some concerns

 

Reason: blinding, patients

Priolkar 2016

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably no

 

Reason: no information reported other than it was a double-blind study

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

High

 

Reason: allocation, blinding, follow-up

Rawat, 2019

Probably yes

 

Reason: use of a computer-generated list

Probably no

 

Reason: not reported

Probably no

 

Reason: no information reported other than it was a double-blind study

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

Some concerns

 

Reason: allocation, blinding

Sanwatsarkar, 2017

Probably yes

 

Reason: Randomization was done by picking random lots from a sealed bag

Probably no

 

Reason: not reported

Probably no

 

Reason: only stated that the drug was loaded by an anesthesiologist who did not participate in the study.

Probably yes

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

Some concerns

 

Reason: allocation, blinding

Shaikh, 2015

 

Probably no

 

Reason: simple lottery method

Probably no

 

Reason: not reported

Probably no

 

Reason: all healthcare personnel, the patients and parents/guardians were blinded

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

Some concerns

 

Reason: allocation

Singh, 2012

 

Probably no

 

Reason: not reported

Probably no

 

Reason: not reported

Probably no

 

Reason: it is only reported that the caudal anesthesia was given by anesthesia technicians, who were blinded about the drugs being used

Probably no

 

Reason: not reported

Probably yes

 

Reason: all relevant outcomes were reported, but absolute data not reported or not readable

Reason: No other problems noted

High

 

Reason: allocation, blinding, follow-up

Tripi, 2005

Probably no

 

Reason: randomization by random number assignment

Probably no

 

Reason: not reported

Probably yes

 

Reason: The anesthesiologist,

surgeon and nurses caring for each patient were blinded to the contents of the administered solution, which was prepared by an anesthesia provider not caring for the patient.

Probably no

 

Reason: not reported

Probably no

 

Reason: results only in text, without absolute values

Reason: No other problems noted

High

 

Reason: allocation, reporting of results

Visoiu 2021

Definitely yes

 

Reason: computer-generated random number table.

Probably yes

 

Reason: The study medications were prepared and labeled as study drug by the pharmacy and released in identical syringes with a volume of 11 ml each.

Probably yes

 

Reason: Patients as well as all members of the care team, except the pharmacist, were blinded to group allocation.

Definitely no

 

Reason: loss to follow-up described in consort flow diagram

Probably yes

 

Reason: all (mean) data of relevant outcome measures provided

 

Reason: No other problems noted

Low

 

Table of excluded studies

Reference

Reason for exclusion

Ansermino, M. and Basu, R. and Vandebeek, C. and Montgomery, C.

more recent SR available

Engelman, E. and Marsala, C.

no quality assessment

Lundblad, M. and Trifa, M. and Kaabachi, O. and Ben Khalifa, S. and Fekih Hassen, A. and Engelhardt, T. and Eksborg, S. and Lönnqvist, P. A.

more recent SR available

Schnabel, A. and Poepping, D. M. and Pogatzki-Zahn, E. M. and Zahn, P. K.

no quality assessment

Shah, Ushma J. and Karuppiah, Niveditha and Karapetyan, Hovhannes and Martin, Janet and Sehmbi, Herman

more recent SR available

Wang, Y. and Guo, Q. and An, Q. and Zhao, L. and Wu, M. and Guo, Z. and Zhang, C.

no quality assessment

Xiong, C. and Han, C. and Lv, H. and Xu, D. and Peng, W. and Zhao, D. and Lan, Z.

more recent SR available

Ahuja, S. and Aggarwal, M. and Joshi, N. and Chaudhry, S. and Madhu, S. V.

Not conform PICO (I/C): wrong comparison (fentanyl vs. clonidine)

Bhowmick, D. K. and Akhtaruzzaman, K. M. and Ahmed, N. and Islam, M. S. and Hossain, M. M. and Islam, M. M.

Article not retrectable

Bonisson, A. C. M. and Fernandes, M. L. and Araújo, G. F. and Vieira, F. E. and Noronha, L. M. and Gomez, R. S.

Wrong language: Portuguese

Chandrakant, Prasad and Vinod Kumar, Verma and Arvind, Kumar and Neeraj, Kumar and Gunjan, Kumar

Not conform PICO (I/C): wrong comparison (different doses of clonidine were compared)

Gogoi, Saurov and Saikia, Diganta and Dey, Sandeep

Not conform PICO (I/C): wrong comparison (clonidine vs. dexmedetomidine)

Kaabachi, O. and Rajeb, A. B. and Mebazaa, M. and Safi, H. and Jelel, C. and Ghachem, M. B. and Ammar, M. S. B.

Not conform PICO (O): none of the crucial outcomes are reported

Khakurel, S. and Sapkota, S. and Karki, A. J.

Not conform PICO (O): none of the crucial outcomes are reported

Klamt, J. G. and Garcia, L. V. and Stocche, R. M. and Meinberg, A. C.

Not conform PICO (I/C): wrong comparison (different doses of clonidine were compared)

Kumar, S. and Kumar, N.

Not conform PICO (O): other primary outcomes and for outcomes of interest (pain) the article only reports statistically significant values among all the analysed one

Lak, M. and Araghizadeh, H. and Shayeghi, S. and Khatibi, B.

Not conform PICO (O): none of the crucial outcomes are reported

Manickam, A. and Vakamudi, M. and Parameswari, A. and Chetan, C.

Not conform PICO (O): none of the crucuial outcomes are reported

Neogi, M. and Bhattacharjee, D. P. and Dawn, S. and Chatterjee, N.

Not conform PICO (O): none of the crucial outcomes are reported

Oner, S. O. and Tercan, E. and Boyaci, A. and Velibasoglu, H. and Ersoy, O. and Esmaoglu, A.

Wrong language: Turkish

Paul, S. and Bhattacharjee, D. P. and Nayek, S. and Chatterjee, N. and Sinha, N.

Not conform PICO (O): none of the crucial outcomes are reported

Ribeiro Jr, O. D. and de Abreu, L. C. and Valenti, V. E. and Cisternas, J. R. and Saletti, D. and Lima, C. J. B. and Silvestre, D. N. and Godoy, I. R. B. and Mello, L. G. M. and Nascimento, V. B. and Martins, L. C.

Not conform PICO (O): crucial outcome measures not reported as data; only used as indication for purpose of evaluation of duration of postoperative analgesia

Wheeler, M. and Patel, A. and Suresh, S. and Roth, A. G. and Birmingham, P. K. and Heffner, C. L. and Coté, C. J.

Not conform PICO (C); bupivacaine and epinephrine

Yildiz, T. S. and Korkmaz, F. and Solak, M. and Toker, K.

Not conform PICO (O): crucial outcome measures not reported as data; only used as indication for purpose of evaluation of duration of postoperative analgesia

Bock, M. and Kunz, P. and Schreckenberger, R. and Graf, B. M. and Martin, E. and Motsch, J.

Not conform PICO (O): none of the crucial outcomes are reported

Cucchiaro, G. and Dagher, C. and Baujard, C. and Dubousset, A. M. and Benhamou, D.

Not conform PICO (I/C): wrong comparison (clonidine vs. morphine)

Fernandes, M. L. and Tibúrcio, M. A. and Pires, K. C. C. and Gomez, R. S.

Not conform PICO (C): bupivacaine 0.166% with epinephrine 1:600

Lundblad, Marit and Lonnqvist, Per-Arne

Wrong study design

Petroheilou, K. and Livanios, S. and Zavras, N. and Hager, J. and Fassoulaki, A.

Not conform PICO (I/C): wrong comparison (clonidine vs. clonidine plus ropivacaine) and none of the crucial outcomes are reported

Petrova, B. and Gavrillova, N. and Koceva, Sv and Boyadjieva, St and Yaneva, D.

Not conform PICO (C): Chirocaine, Lidocaine

Sardar, Arijit and Prasad, Ganga and Arora, Mahesh Kumar and Kashyap, Lokesh

Not conform PICO (I/C): wrong comparison (midazolam and bupivacaine vs. midazolam with oral clonidine and bupivacaine)

Archana, K. N. and Vyshnavi, S. and Ganesh, Vinutha

Not conform PICO (O): none of the crucial outcomes are reported

Barbero, G. E. and de Miguel, M. and Sierra, P. and Merritt, G. and Bora, P. and Borah, N. and Ciarallo, C. and Ing, R. and Bosenberg, A. and de Nadal, M.

Not conform PICO (O): none of the crucial outcomes are reported

Batra, Y. K. and Rakesh, S. V. and Panda, N. B. and Lokesh, V. C. and Subramanyam, R.

Not conform PICO (O): none of the crucial outcomes are reported

Chalkiadis, G. A. and Sommerfield, D. and Low, J. and Orsini, F. and Dowden, S. J. and Tay, M. and Penrose, S. and Pirpiris, M. and Graham, H. K.

Not conform PICO (I/C): wrong comparison (clonidine vs. fentanyl)

Cucchiaro, G. and Adzick, S. N. and Rose, J. B. and Maxwell, L. and Watcha, M.

Not conform PICO (I/C): wrong comparisons (bupivacaine + fentanyl, bupivacaine + clonidine, bupivacaine + fentanyl + clonidine)

Disma, N. and Frawley, G. and Mameli, L. and Pistorio, A. and Alberighi, O. D. C. and Montobbio, G. and Tuo, P.

Not conform PICO (I/C): wrong comparison (Patients were allocated to one of three groups (msexcel
generated randomization sequence) to receive a
mixture of levobupivacaine  with 1 (Group LC1), 2 (Group LC2), or 3
(Group LC3) μg·kg-1 of clonidine)

Fonseca, N. M. and De Oliveira, C. A.

Not conform PICO (P): wrong patient group (16 to 57 years of age)

Giannoni, C. and White, S. and Enneking, F. K. and Morey, T.

Not conform PICO (I/C): wrong comparison (tonsillar fossae of isotonic sodium chloride, ropivacaine, or ropivacaine plus clonidine prior to tonsil excision)

Hansen, T. G. and Henneberg, S. W. and Walther-Larsen, S. and Lund, J. and Hansen, M.

Not conform PICO (I/C): wrong comparison (caudal vs. i.v. clonidine)

Ivani, G. and Conio, A. and De Negri, P. and Eksborg, S. and Lönnqvist, P. A.

Not conform PICO (I/C): wrong comparison a caudal block (ropivacaine 0.2%, 1 ml·kg-1 + clonidine 2 μg·kg-1) vs.  an ilioinguinal-iliohypogastric nerve block (ropivacaine 0.2%, 0.4 ml·kg-1 + clonidine 2 μg·kg-1)

Jarraya, A. and Elleuch, S. and Zouari, J. and Smaoui, M. and Laabidi, S. and Kolsi, K.

Not conform PICO (I/C): wrong comparison (bupivacaine with fentanyl and clonidine vs. bupivacaine with fentanyl)

Khatavkar, S. S. and Lonkar, S. S. and Panchal, P. B. and Thatte, W. S. and Nagendra, S. and Tewari, D.

Not conform PICO (I/C): wrong comparison (ropivacaine 0.25% plus fentanyl vs. ropivacaine 0.25% plus clonidine)

Sharma, Rohan and Kamal, Geeta and Agarwal, Shilpa and Gupta, Anju and Gupta, Aikta and Kalra, Bhumika

Not conform PICO (I/C): wrong comparison (different doses of clonidine were compared)

Shukla, B. U. and Prabhakar, T. and Malhotra, K.

Not conform PICO (I/C): wrong comparison (clonidine vs. fentanyl)

Sinha, Chandni and Kumar, Bindey and Bhadani, Umesh Kumar and Kumar, Ajeet and Kumar, Amarjeet and Ranjan, Alok

Not conform PICO (I/C): wrong comparison (dexamethasone vs. clonidine)

Vetter, T. R. and Carvallo, D. and Johnson, J. L. and Mazurek, M. S. and Presson Jr, R. G.

Not conform PICO (I/C): wrong comparison (clonidine vs. hydromorphone vs. morphine)

Wheeler, Melissa and Patel, Arti and Suresh, Santhanam and Roth, Andrew G. and Birmingham, Patrick K. and Heffner, Corri L. and Cote, Charles J.

Not conform PICO (I/C): wrong comparison (bupivacaine with fresh epinephrine and clonidine vs. bupivacaine with epinephrine)

Kaabachi O, Zerelli Z, Methamem M, Abdelaziz AB, Moncer K, Toumi M. Clonidine administered as adjuvant for bupivacaine in ilioinguinal-iliohypogastric nerve block does not prolong postoperative analgesia. Paediatr Anaesth. 2005 Jul;15(7):586-90. doi: 10.1111/j.1460-9592.2005.01497.x. PMID: 15960643.

Not conform PICO, wrong outcomes

Cao JP, Miao XY, Liu J, Shi XY. An evaluation of intrathecal bupivacaine combined with intrathecal or intravenous clonidine in children undergoing orthopedic surgery: a randomized double-blinded study. Paediatr Anaesth. 2011 Apr;21(4):399-405. doi: 10.1111/j.1460-9592.2011.03543.x. PMID: 21371167.

Not conform PICO, intrathecal administration of LA with or without clonidine iv

 

Autorisatiedatum en geldigheid

Laatst beoordeeld  : 17-12-2024

Laatst geautoriseerd  : 17-12-2024

Geplande herbeoordeling  : 17-12-2028

Initiatief en autorisatie

Initiatief:
  • Nederlandse Vereniging voor Anesthesiologie
Geautoriseerd door:
  • Nederlandse Orthopaedische Vereniging
  • Nederlandse Vereniging voor Anesthesiologie
  • Nederlandse Vereniging voor Heelkunde
  • Verpleegkundigen en Verzorgenden Nederland
  • Nederlandse Vereniging van Ziekenhuisapothekers
  • Stichting Kind en Ziekenhuis

Algemene gegevens

De ontwikkeling/herziening van deze richtlijn werd ondersteund door het Kennisinstituut van de Federatie Medisch Specialisten (www.demedischspecialist.nl/kennisinstituut) en werd gefinancierd uit de Kwaliteitsgelden Medisch Specialisten (SKMS). De financier heeft geen enkele invloed gehad op de inhoud van de richtlijnmodule.

Samenstelling werkgroep

Voor het ontwikkelen van de richtlijn is in 2022 een multidisciplinaire werkgroep ingesteld, bestaande uit vertegenwoordigers van alle relevante specialismen (zie hiervoor de Samenstelling van de werkgroep) die betrokken zijn bij de zorg voor kinderen met postoperatieve pijn.

 

Werkgroep

Dr. L.M.E. (Lonneke) Staals, anesthesioloog, voorzitter, NVA

Dr. C.M.A. (Caroline) van den Bosch, anesthesioloog-pijnspecialist, NVA

Drs. A.W. (Alinde) Hindriks-Keegstra, anesthesioloog, NVA

Drs. G.A.J. (Geranne) Hopman, anesthesioloog, NVA

Drs. L.J.H. (Lea) van Wersch, anesthesioloog, NVA

Dr. C.M.G. (Claudia) Keyzer-Dekker, kinderchirurg, NVvH

Drs. F.L. (Femke) van Erp Taalman Kip, orthopedisch kinderchirurg, NOV

Dr. L.M.A. (Laurent) Favié, ziekenhuisapotheker, NVZA

J. (Jantine) Boerrigter-van Ginkel, verpleegkundig specialist kinderpijn, V&VN

S. (Sharine) van Rees-Florentina, recovery verpleegkundige, BRV

E.C. (Esen) Doganer en M. (Marjolein) Jager, beleidsmedewerker, Kind & Ziekenhuis

 

Klankbordgroep

Dr. L.M. (Léon) Putman, cardiothoracaal chirurg, NVT

R. (Remko) ter Riet, MSc, anesthesiemedewerker/physician assistant, NVAM

Drs. L.I.M. (Laura) Meltzer, KNO-arts, NVKNO

 

Met ondersteuning van

Dr. L.M.P. Wesselman, adviseur, Kennisinstituut van de Federatie Medisch Specialisten

I. van Dijk, junior adviseur, Kennisinstituut van de Federatie Medisch Specialisten

Belangenverklaringen

De Code ter voorkoming van oneigenlijke beïnvloeding door belangenverstrengeling is gevolgd. Alle werkgroepleden hebben schriftelijk verklaard of zij in de laatste drie jaar directe financiële belangen (betrekking bij een commercieel bedrijf, persoonlijke financiële belangen, onderzoeksfinanciering) of indirecte belangen (persoonlijke relaties, reputatiemanagement) hebben gehad. Gedurende de ontwikkeling of herziening van een module worden wijzigingen in belangen aan de voorzitter doorgegeven. De belangenverklaring wordt opnieuw bevestigd tijdens de commentaarfase.

Een overzicht van de belangen van werkgroepleden en het oordeel over het omgaan met eventuele belangen vindt u in onderstaande tabel. De ondertekende belangenverklaringen zijn op te vragen bij het secretariaat van het Kennisinstituut van de Federatie Medisch Specialisten.

 

Werkgroeplid

Functie

Nevenfuncties

Gemelde belangen

Ondernomen actie

L.M.E. Staals (voorzitter)

Anesthesioloog

Sectorhoofd Kinder- en Obstetrische anesthesiologie

Universitair Docent

Erasmus MC Sophia Kinderziekenhuis, Rotterdam

Lid wetenschapcommissie Sectie Kinderanesthesiologie (NVA) (onbetaald)

Lid scientific forum ESAIC/Devices abd Technology (onbetaald)

Lid werkgroep Landelijke Kwaliteitsregistratie Amandeloperaties (NVKNO/NVA) (onbetaald)

MSD/ Merck: i.v.m. een clinical trial naar sugammadex bij kinderen: Consultant of Global Clinical Trial Operations in the Netherlands. Betaald (inkomsten gaan op onderzoekskostenplaats van de afdeling Anesthesiologie Erasmus MC Sophia). Dit onderzoek gaat over sugammadex (antagonist voor spierverslapping).

Klinisch onderzoek gedaan naar postoperatieve pijnstilling bij kinderen na buikchirurgie, d.m.v. wondcatheter met lokaal anestheticum (nog niet gepubliceerd, daarom niet meegenomen in search van de richtlijn). Er is geen belang bij het advies van de richtlijn.

Geen restricties

C.M.A. van den Bosch

Anesthesioloog - pijnspecialist Prinses Maxima Centrum

Geen

Geen

Geen restricties

A.W. Hindriks-Keegstra

Anesthesioloog UMC Utrecht

 

Geen

VR ter behandeling van postoperatieve pijn en angst bij kinderen.

Geen restricties. Extern gefinancierd onderzoek valt buiten bestek van de richtlijn

G.A.J. Hopman

Anesthesioloog, Radboud UMC, Nijmegen

Geen

Geen

Geen restricties

L.J.H. van Wersch

Anesthesioloog, Maasziekenhuis Pantein

Geen

Geen

Geen restricties

C.M.G. Keyzer-Dekker

Kinderchirurg, Erasmus MC Sophia.

Geen

Geen

Geen restricties

F.L. van Erp Taalman Kip

Orthopedisch kinderchirurg, Erasmus Medisch Centrum Rotterdam

-Docent Fontys Hogeschool Eindhoven, curriculum kinder- podotherapie

-Docent TNO Leiden, onderwijs Jeugdartsen,

- Trainer stichting Skills4Comfort

Geen

Geen restricties

L.M.A. Favié

Ziekenhuisapotheker Erasmus MC

Geen

Geen

Geen restricties

J.Boerrigter-van Ginkel

Verpleegkundig Specialist Kinderpijn, Wilhelmina Ziekenhuis Utrecht.

Geen

Geen

Geen restricties

S. van Rees-Florentina

Recovery verpleegkundige Flevoziekenhuis Almere
Pijnconsulent i.o. Flevoziekenhuis Almere

Bestuurslid BRV BRN Nederland

 

Geen

Geen restricties

E.C. Doganer

Stichting Kind&Ziekenhuis Junior Projectmanager/beleidsmedewerker

Geen

Geen

Geen restricties

M. Jager

Stichting Kind&Ziekenhuis Junior Projectmanager/beleidsmedewerker

Begeleider C bij Sherpa, betaald

Geen

Geen restricties

Klankbordgroeplid

Functie

Nevenfuncties

Gemelde belangen

Ondernomen actie

L.M. Putman

Congenitaal cardio-thoracaal chirurg, Leids Universitair Medisch Centrum & Amsterdam UMC, voltijd functie

Geen

Geen

Geen restricties

R. ter Riet

Anesthesiemedewerker/Physician Assistant Anesthesiologie/Pijngeneeskunde

Voorzitter NVAM, Voorzitter commissie (acute) pijn NVAM/V&VN

Geen

Geen restricties

L.I.M. Meltzer

Beatrix ziekenhuis Gorinchem, Rivas zorggroep

Geen

Geen

Geen restricties

 

Inbreng patiëntenperspectief

Er werd aandacht besteed aan het patiëntenperspectief door zitting van een afgevaardigde van de patiëntenvereniging (Stichting Kind & Ziekenhuis) in de werkgroep. De conceptrichtlijn is tevens voor commentaar voorgelegd aan de Patiëntenfederatie Nederland en Stichting Kind & Ziekenhuis en de eventueel aangeleverde commentaren zijn bekeken en verwerkt.

 

Wkkgz & Kwalitatieve raming van mogelijke substantiële financiële gevolgen

Kwalitatieve raming van mogelijke financiële gevolgen in het kader van de Wkkgz

Bij de richtlijn is conform de Wet kwaliteit, klachten en geschillen zorg (Wkkgz) een kwalitatieve raming uitgevoerd of de aanbevelingen mogelijk leiden tot substantiële financiële gevolgen. Bij het uitvoeren van deze beoordeling zijn richtlijnmodules op verschillende domeinen getoetst (zie het stroomschema op de Richtlijnendatabase).

 

Uit de kwalitatieve raming blijkt dat er waarschijnlijk geen substantiële financiële gevolgen zijn.

Werkwijze

AGREE

Deze richtlijnmodule is opgesteld conform de eisen vermeld in het rapport Medisch Specialistische Richtlijnen 2.0 van de adviescommissie Richtlijnen van de Raad Kwaliteit. Dit rapport is gebaseerd op het AGREE II instrument (Appraisal of Guidelines for Research & Evaluation II; Brouwers, 2010).

 

Knelpuntenanalyse en uitgangsvragen

Tijdens de voorbereidende fase inventariseerde de werkgroep de knelpunten in de zorg voor kinderen met postoperatieve pijn. De werkgroep beoordeelde de aanbevelingen uit de eerdere richtlijn Postoperatieve pijn (NVA, 2013) op noodzaak tot revisie. Het raamwerk van de richtlijn voor volwassenen is ook kritisch bekeken als uitgangspunt. Op basis van de uitkomsten van de knelpuntenanalyse zijn door de werkgroep concept-uitgangsvragen opgesteld en definitief vastgesteld.

 

Uitkomstmaten

Na het opstellen van de zoekvraag behorende bij de uitgangsvraag inventariseerde de werkgroep welke uitkomstmaten voor de patiënt relevant zijn, waarbij zowel naar gewenste als ongewenste effecten werd gekeken. Hierbij werd een maximum van acht uitkomstmaten gehanteerd. De werkgroep waardeerde deze uitkomstmaten volgens hun relatieve belang bij de besluitvorming rondom aanbevelingen, als cruciaal (kritiek voor de besluitvorming), belangrijk (maar niet cruciaal) en onbelangrijk. Tevens definieerde de werkgroep tenminste voor de cruciale uitkomstmaten welke verschillen zij klinisch (patiënt) relevant vonden.

 

Methode literatuursamenvatting

Een uitgebreide beschrijving van de strategie voor zoeken en selecteren van literatuur is te vinden onder ‘Zoeken en selecteren’ onder Onderbouwing. Indien mogelijk werd de data uit verschillende studies gepoold in een random-effects model. Review Manager 5.4 werd gebruikt voor de statistische analyses. De beoordeling van de kracht van het wetenschappelijke bewijs wordt hieronder toegelicht.

 

Beoordelen van de kracht van het wetenschappelijke bewijs

De kracht van het wetenschappelijke bewijs werd bepaald volgens de GRADE-methode. GRADE staat voor ‘Grading Recommendations Assessment, Development and Evaluation’ (zie http://www.gradeworkinggroup.org/). De basisprincipes van de GRADE-methodiek zijn: het benoemen en prioriteren van de klinisch (patiënt) relevante uitkomstmaten, een systematische review per uitkomstmaat, en een beoordeling van de bewijskracht per uitkomstmaat op basis van de acht GRADE-domeinen (domeinen voor downgraden: risk of bias, inconsistentie, indirectheid, imprecisie, en publicatiebias; domeinen voor upgraden: dosis-effect relatie, groot effect, en residuele plausibele confounding).

GRADE onderscheidt vier gradaties voor de kwaliteit van het wetenschappelijk bewijs: hoog, redelijk, laag en zeer laag. Deze gradaties verwijzen naar de mate van zekerheid die er bestaat over de literatuurconclusie, in het bijzonder de mate van zekerheid dat de literatuurconclusie de aanbeveling adequaat ondersteunt (Schünemann, 2013; Hultcrantz, 2017).

 

GRADE

Definitie

Hoog

  • er is hoge zekerheid dat het ware effect van behandeling dicht bij het geschatte effect van behandeling ligt;
  • het is zeer onwaarschijnlijk dat de literatuurconclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Redelijk

  • er is redelijke zekerheid dat het ware effect van behandeling dicht bij het geschatte effect van behandeling ligt;
  • het is mogelijk dat de conclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Laag

  • er is lage zekerheid dat het ware effect van behandeling dicht bij het geschatte effect van behandeling ligt;
  • er is een reële kans dat de conclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Zeer laag

  • er is zeer lage zekerheid dat het ware effect van behandeling dicht bij het geschatte effect van behandeling ligt;
  • de literatuurconclusie is zeer onzeker.

 

Bij het beoordelen (graderen) van de kracht van het wetenschappelijk bewijs in richtlijnen volgens de GRADE-methodiek spelen grenzen voor klinische besluitvorming een belangrijke rol (Hultcrantz, 2017). Dit zijn de grenzen die bij overschrijding aanleiding zouden geven tot een aanpassing van de aanbeveling. Om de grenzen voor klinische besluitvorming te bepalen moeten alle relevante uitkomstmaten en overwegingen worden meegewogen. De grenzen voor klinische besluitvorming zijn daarmee niet één op één vergelijkbaar met het minimaal klinisch relevant verschil (Minimal Clinically Important Difference, MCID). Met name in situaties waarin een interventie geen belangrijke nadelen heeft en de kosten relatief laag zijn, kan de grens voor klinische besluitvorming met betrekking tot de effectiviteit van de interventie bij een lagere waarde (dichter bij het nuleffect) liggen dan de MCID (Hultcrantz, 2017).

 

De beoordelingen van de literatuur en de conclusies zijn gedaan op basis van de GRADE systematiek. De werkgroep vindt het belangrijk om relevante beperkingen hiervan aan te geven.

 

De klinische vragen in deze richtlijn gaan veelal over een reductie van postoperatieve pijn en opioïdenconsumptie bij een individuele patiënt. Onderzoeken beschrijven de verschillen op groepsniveau, over studies met verschillende patiëntpopulaties en operaties heen. Opioïdenconsumptie is sterk afhankelijk van tijdstip, ingreep en ernst van de pijn. Door het werken met een absolute drempelwaarde in mg (i.p.v. een relatieve drempelwaarde in %) bereiken resultaten gemeten op vroege postoperatieve tijdstippen en in studies met ingrepen met relatief lage opioïdenconsumptie vaak niet de MCID. Daarbij komt ook dat de doelgroep van de huidige richtlijn enorm varieert in lengte en gewicht (van prematuur tot adolescent). Lengte en gewicht heeft grote invloed op het analgetische effect van een specifieke dosering, waardoor alleen kijken naar milligrammen niet volstaat. Waar mogelijk is ook de relatieve reductie in procenten beschreven.

De keuze van de MCID (absoluut verschil in pijnscore of opioïdenconsumptie) heeft een bepaalde mate van willekeurigheid en is niet absoluut te zien. Ook zijn de conclusies zo geformuleerd (en geven alleen beperkt antwoord op het effect op een individuele patiënt voor een specifieke ingreep). In de literatuur worden de eindpunten pijnscores en opioïdenconsumptie separaat van elkaar weer gegeven, suggererend dat deze onafhankelijk van elkaar zijn. Echter kunnen deze twee eindpunten niet onafhankelijk van elkaar beoordeeld worden; in ieder protocol is opgenomen dat pijn behandeld moet worden. Deze separate beoordeling geeft niet altijd een adequaat antwoord op de klinische vraag naar het analgetische effect van een interventie.

Daarnaast worden multimodale componenten als aparte interventies beoordeeld, echter de klinische vraag is naar de effectiviteit als bouwsteen van een multimodale werkwijze.

Voor doseringsadviezen wordt er verwezen naar betrouwbare bronnen, zoals het farmacotherapeutisch kompas of het kinderformularium.

 

Overwegingen (van bewijs naar aanbeveling)

Om te komen tot een aanbeveling zijn naast (de kwaliteit van) het wetenschappelijke bewijs ook andere aspecten belangrijk en worden meegewogen, zoals aanvullende argumenten uit bijvoorbeeld de biomechanica of fysiologie, waarden en voorkeuren van patiënten, kosten (middelenbeslag), aanvaardbaarheid, haalbaarheid en implementatie. Deze aspecten zijn systematisch vermeld en beoordeeld (gewogen) onder het kopje ‘Overwegingen’ en kunnen (mede) gebaseerd zijn op expert opinion. Hierbij is gebruik gemaakt van een gestructureerd format gebaseerd op het evidence-to-decision framework van de internationale GRADE Working Group (Alonso-Coello, 2016a; Alonso-Coello 2016b). Dit evidence-to-decision framework is een integraal onderdeel van de GRADE methodiek.

 

Formuleren van aanbevelingen

De aanbevelingen geven antwoord op de uitgangsvraag en zijn gebaseerd op het beschikbare wetenschappelijke bewijs en de belangrijkste overwegingen, en een weging van de gunstige en ongunstige effecten van de relevante interventies. De kracht van het wetenschappelijk bewijs en het gewicht dat door de werkgroep wordt toegekend aan de overwegingen, bepalen samen de sterkte van de aanbeveling. Conform de GRADE-methodiek sluit een lage bewijskracht van conclusies in de systematische literatuuranalyse een sterke aanbeveling niet a priori uit, en zijn bij een hoge bewijskracht ook zwakke aanbevelingen mogelijk (Agoritsas, 2017; Neumann, 2016). De sterkte van de aanbeveling wordt altijd bepaald door weging van alle relevante argumenten tezamen. De werkgroep heeft bij elke aanbeveling opgenomen hoe zij tot de richting en sterkte van de aanbeveling zijn gekomen.

In de GRADE-methodiek wordt onderscheid gemaakt tussen sterke en zwakke (of conditionele) aanbevelingen. De sterkte van een aanbeveling verwijst naar de mate van zekerheid dat de voordelen van de interventie opwegen tegen de nadelen (of vice versa), gezien over het hele spectrum van patiënten waarvoor de aanbeveling is bedoeld. De sterkte van een aanbeveling heeft duidelijke implicaties voor patiënten, behandelaars en beleidsmakers (zie onderstaande tabel). Een aanbeveling is geen dictaat, zelfs een sterke aanbeveling gebaseerd op bewijs van hoge kwaliteit (GRADE gradering HOOG) zal niet altijd van toepassing zijn, onder alle mogelijke omstandigheden en voor elke individuele patiënt.

 

Implicaties van sterke en zwakke aanbevelingen voor verschillende richtlijngebruikers

 

 

Sterke aanbeveling

Zwakke (conditionele) aanbeveling

Voor patiënten

De meeste patiënten zouden de aanbevolen interventie of aanpak kiezen en slechts een klein aantal niet.

Een aanzienlijk deel van de patiënten zouden de aanbevolen interventie of aanpak kiezen, maar veel patiënten ook niet.

Voor behandelaars

De meeste patiënten zouden de aanbevolen interventie of aanpak moeten ontvangen.

Er zijn meerdere geschikte interventies of aanpakken. De patiënt moet worden ondersteund bij de keuze voor de interventie of aanpak die het beste aansluit bij zijn of haar waarden en voorkeuren.

Voor beleidsmakers

De aanbevolen interventie of aanpak kan worden gezien als standaardbeleid.

Beleidsbepaling vereist uitvoerige discussie met betrokkenheid van veel stakeholders. Er is een grotere kans op lokale beleidsverschillen.

 

Organisatie van zorg

In de knelpuntenanalyse en bij de ontwikkeling van de richtlijn is expliciet aandacht geweest voor de organisatie van zorg: alle aspecten die randvoorwaardelijk zijn voor het verlenen van zorg (zoals coördinatie, communicatie, (financiële) middelen, mankracht en infrastructuur). Randvoorwaarden die relevant zijn voor het beantwoorden van deze specifieke uitgangsvraag zijn genoemd bij de overwegingen. Meer algemene, overkoepelende, of bijkomende aspecten van de organisatie van zorg worden behandeld in de module Organisatie van zorg.

 

Commentaar- en autorisatiefase

De conceptrichtlijn werd aan de betrokken (wetenschappelijke) verenigingen en (patiënt) organisaties voorgelegd ter commentaar. De commentaren werden verzameld en besproken met de werkgroep. Naar aanleiding van de commentaren werd de conceptrichtlijn aangepast en definitief vastgesteld door de werkgroep. De definitieve richtlijn werd aan de deelnemende (wetenschappelijke) verenigingen en (patiënt) organisaties voorgelegd voor autorisatie en door hen geautoriseerd dan wel geaccordeerd.

 

Literatuur

Agoritsas T, Merglen A, Heen AF, Kristiansen A, Neumann I, Brito JP, Brignardello-Petersen R, Alexander PE, Rind DM, Vandvik PO, Guyatt GH. UpToDate adherence to GRADE criteria for strong recommendations: an analytical survey. BMJ Open. 2017 Nov 16;7(11):e018593. doi: 10.1136/bmjopen-2017-018593. PubMed PMID: 29150475; PubMed Central PMCID: PMC5701989.

 

Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, Morelli A, Guyatt GH, Oxman AD; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016 Jun 28;353:i2016. doi: 10.1136/bmj.i2016. PubMed PMID: 27353417.

 

Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Vandvik PO, Meerpohl J, Guyatt GH, Schünemann HJ; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016 Jun 30;353:i2089. doi: 10.1136/bmj.i2089. PubMed PMID: 27365494.

 

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. Review. PubMed PMID: 20603348; PubMed Central PMCID: PMC3001530.

 

Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, Alper BS, Meerpohl JJ, Murad MH, Ansari MT, Katikireddi SV, Östlund P, Tranæus S, Christensen R, Gartlehner G, Brozek J, Izcovich A, Schünemann H, Guyatt G. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017 Jul;87:4-13. doi: 10.1016/j.jclinepi.2017.05.006. Epub 2017 May 18. PubMed PMID: 28529184; PubMed Central PMCID: PMC6542664.

 

Medisch Specialistische Richtlijnen 2.0 (2012). Adviescommissie Richtlijnen van de Raad Kwalitieit. http://richtlijnendatabase.nl/over_deze_site/over_richtlijnontwikkeling.html

 

Neumann I, Santesso N, Akl EA, Rind DM, Vandvik PO, Alonso-Coello P, Agoritsas T, Mustafa RA, Alexander PE, Schünemann H, Guyatt GH. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J Clin Epidemiol. 2016 Apr;72:45-55. doi: 10.1016/j.jclinepi.2015.11.017. Epub 2016 Jan 6. Review. PubMed PMID: 26772609.

 

Schünemann H, Brożek J, Guyatt G, et al. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available from http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html.

Zoekverantwoording

Zoekacties zijn opvraagbaar. Neem hiervoor contact op met de Richtlijnendatabase.